cis-acting	B-DNA
sequences	I-DNA
required	O
for	O
inducible	O
interleukin-2	B-DNA
enhancer	I-DNA
function	O
bind	O
a	O
novel	O
Ets-related	B-protein
protein	I-protein
,	O
Elf-1	B-protein
.	O

The	O
recent	O
definition	O
of	O
a	O
consensus	O
DNA	B-DNA
binding	I-DNA
sequence	I-DNA
for	O
the	O
Ets	B-protein
family	I-protein
of	O
transcription	B-protein
factors	I-protein
has	O
allowed	O
the	O
identification	O
of	O
potential	O
Ets	B-DNA
binding	I-DNA
sites	I-DNA
in	O
the	O
promoters	B-DNA
and	O
enhancers	B-DNA
of	O
many	O
inducible	B-DNA
T-cell	I-DNA
genes	I-DNA
.	O

In	O
the	O
studies	O
described	O
in	O
this	O
report	O
,	O
we	O
have	O
identified	O
two	O
potential	O
Ets	B-DNA
binding	I-DNA
sites	I-DNA
,	O
EBS1	O
and	O
EBS2	B-DNA
,	O
which	O
are	O
conserved	O
in	O
both	O
the	O
human	B-DNA
and	I-DNA
murine	I-DNA
interleukin-2	I-DNA
enhancers	I-DNA
.	O

Within	O
the	O
human	B-DNA
enhancer	I-DNA
,	O
these	O
two	O
sites	O
are	O
located	O
within	O
the	O
previously	O
defined	O
DNase	B-protein
I	I-protein
footprints	O
,	O
NFAT-1	B-DNA
and	O
NFIL-2B	B-DNA
,	O
respectively	O
.	O

Electrophoretic	O
mobility	O
shift	O
and	O
methylation	O
interference	O
analyses	O
demonstrated	O
that	O
EBS1	O
and	O
EBS2	B-DNA
are	O
essential	O
for	O
the	O
formation	O
of	O
the	O
NFAT-1	B-protein
and	I-protein
NFIL-2B	I-protein
nuclear	I-protein
protein	I-protein
complexes	I-protein
.	O

Furthermore	O
,	O
in	O
vitro	O
mutagenesis	O
experiments	O
demonstrated	O
that	O
inducible	O
interleukin-2	B-DNA
enhancer	I-DNA
function	O
requires	O
the	O
presence	O
of	O
either	O
EBS1	O
or	O
EBS2	B-DNA
.	O

Two	O
well-characterized	O
Ets	B-protein
family	I-protein
members	I-protein
,	O
Ets-1	B-protein
and	O
Ets-2	B-protein
,	O
are	O
reciprocally	O
expressed	O
during	O
T-cell	O
activation	O
.	O

Surprisingly	O
,	O
however	O
,	O
neither	O
of	O
these	O
proteins	O
bound	O
in	O
vitro	O
to	O
EBS1	O
or	O
EBS2	B-DNA
.	O

We	O
therefore	O
screened	O
a	O
T-cell	B-DNA
cDNA	I-DNA
library	O
under	O
low-stringency	O
conditions	O
with	O
a	O
probe	O
from	O
the	O
DNA	B-protein
binding	I-protein
domain	I-protein
of	O
Ets-1	B-protein
and	O
isolated	O
a	O
novel	B-protein
Ets	I-protein
family	I-protein
member	I-protein
,	O
Elf-1	B-protein
.	O

Elf-1	B-protein
contains	O
a	O
DNA	B-protein
binding	I-protein
domain	I-protein
that	O
is	O
nearly	O
identical	O
to	O
that	O
of	O
E74	B-protein
,	O
the	O
ecdysone-inducible	B-protein
Drosophila	I-protein
transcription	I-protein
factor	I-protein
required	O
for	O
metamorphosis	O
(	O
hence	O
the	O
name	O
Elf-1	B-protein
,	O
for	O
E74-like	B-protein
factor	I-protein
1	I-protein
)	O
.	O

Elf-1	B-protein
bound	O
specifically	O
to	O
both	O
EBS1	O
and	O
EBS2	B-DNA
in	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O

It	O
also	O
bound	O
to	O
the	O
purine-rich	B-DNA
CD3R	I-DNA
element	I-DNA
from	O
the	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
type	I-DNA
2	I-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
,	O
which	O
is	O
required	O
for	O
inducible	O
virus	O
expression	O
in	O
response	O
to	O
signalling	O
through	O
the	O
T-cell	B-protein
receptor	I-protein
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
that	O
multiple	B-protein
Ets	I-protein
family	I-protein
members	I-protein
with	O
apparently	O
distinct	O
DNA	O
binding	O
specificities	O
regulate	O
differential	O
gene	O
expression	O
in	O
resting	B-cell_type
and	I-cell_type
activated	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

MoLEcULaR	NULL
anp	NULL
CELLULAR	NULL
Brorogy	NULL
,	NULL
Mar	NULL
.	NULL

1992	NULL
,	NULL
p.	NULL
1043-1053	NULL
0270-7306/92/031043-11	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1992	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

12	NULL
,	NULL
No	NULL
.	NULL

3	NULL
cis-Acting	NULL
Sequences	NULL
Required	NULL
for	NULL
Inducible	NULL
Interleukin-2	NULL
Enhancer	NULL
Function	NULL
Bind	NULL
a	NULL
Novel	NULL
Ets-Related	NULL
Protein	NULL
,	NULL
Elf-1	NULL
CRAIG	NULL
B.	NULL
THOMPSON	NULL
,	NULL
'	NULL
CHUNG-YIH	NULL
WANG	NULL
,	NULL
*	NULL
I-CHENG	NULL
PAUL	NULL
R.	NULL
BOHJANEN	NULL
,	NULL
``	NULL
BRONISLAWA	NULL
PETRYNIAK	NULL
,	NULL
*	NULL
``	NULL
CARL	NULL
H.	NULL
JUNE	NULL
,	NULL
``	NULL
SUSAN	NULL
MIESFELDT	NULL
,	NULL
'	NULL
LIQUIAN	NULL
ZHANG	NULL
,	NULL
**	NULL
GARY	NULL
J.	NULL
NABEL	NULL
,	NULL
**	NULL
BEVERLY	NULL
KARPINSKI	NULL
,	NULL
'	NULL
anp	NULL
JEFFREY	NULL
M.	NULL
LEIDEN'**	NULL
The	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
and	NULL
Departments	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Microbiology/Immunology	NULL
,	NULL
``	NULL
and	NULL
Biological	NULL
Chemistry	NULL
,	NULL
``	NULL
University	NULL
of	NULL
Michigan	NULL
Medical	NULL
Center	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
Michigan	NULL
48109	NULL
,	NULL
and	NULL
Naval	NULL
Medical	NULL
Research	NULL
Institute	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20814°*	NULL
Received	NULL
21	NULL
August	NULL
1991/Accepted	NULL
2	NULL
December	NULL
1991	NULL
The	NULL
recent	NULL
definition	NULL
of	NULL
a	NULL
consensus	NULL
DNA	NULL
binding	NULL
sequence	NULL
for	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
has	NULL
allowed	NULL
the	NULL
identification	NULL
of	NULL
potential	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
promoters	NULL
and	NULL
enhancers	NULL
of	NULL
many	NULL
inducible	NULL
T-cell	NULL
genes	NULL
.	NULL

In	NULL
the	NULL
studies	NULL
described	NULL
in	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
two	NULL
potential	NULL
Ets	NULL
binding	NULL
sites	NULL
,	NULL
EBS1	NULL
and	NULL
EBS2	NULL
,	NULL
which	NULL
are	NULL
conserved	NULL
in	NULL
both	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
interleukin-2	NULL
enhancers	NULL
.	NULL

Within	NULL
the	NULL
human	NULL
enhancer	NULL
,	NULL
these	NULL
two	NULL
sites	NULL
are	NULL
located	NULL
within	NULL
the	NULL
previously	NULL
defined	NULL
DNase	NULL
I	NULL
footprints	NULL
,	NULL
NFAT-1	NULL
and	NULL
NFIL-2B	NULL
,	NULL
respectively	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
and	NULL
methylation	NULL
interference	NULL
analyses	NULL
demonstrated	NULL
that	NULL
EBS1	NULL
and	NULL
EBS2	NULL
are	NULL
essential	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
NFAT-1	NULL
and	NULL
NFIL-2B	NULL
nuclear	NULL
protein	NULL
complexes	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
experiments	NULL
demonstrated	NULL
that	NULL
inducible	NULL
interleukin-2	NULL
enhancer	NULL
function	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
EBS1	NULL
or	NULL
EBS2	NULL
,	NULL
Two	NULL
well-characterized	NULL
Ets	NULL
family	NULL
members	NULL
,	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
,	NULL
are	NULL
reciprocally	NULL
expressed	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

Surprisingly	NULL
,	NULL
however	NULL
,	NULL
neither	NULL
of	NULL
these	NULL
proteins	NULL
bound	NULL
in	NULL
vitro	NULL
to	NULL
EBS1	NULL
or	NULL
EBS2	NULL
.	NULL

We	NULL
therefore	NULL
screened	NULL
a	NULL
T-cell	NULL
cDNA	NULL
library	NULL
under	NULL
low-stringency	NULL
conditions	NULL
with	NULL
a	NULL
probe	NULL
from	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
Ets-1	NULL
and	NULL
isolated	NULL
a	NULL
novel	NULL
Ets	NULL
family	NULL
member	NULL
,	NULL
Elf-1	NULL
.	NULL

Elf-1	NULL
contains	NULL
a	NULL
DNA	NULL
binding	NULL
domain	NULL
that	NULL
is	NULL
nearly	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
E74	NULL
,	NULL
the	NULL
ecdysone-inducible	NULL
Drosophila	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
metamorphosis	NULL
(	NULL
hence	NULL
the	NULL
name	NULL
Elf-1	NULL
,	NULL
for	NULL
E74-like	NULL
factor	NULL
1	NULL
)	NULL
.	NULL

Elf-1	NULL
bound	NULL
specifically	NULL
to	NULL
both	NULL
EBS1	NULL
and	NULL
EBS2	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

It	NULL
also	NULL
bound	NULL
to	NULL
the	NULL
purine-rich	NULL
CD3R	NULL
element	NULL
from	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
long	NULL
terminal	NULL
repeat	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
inducible	NULL
virus	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
signalling	NULL
through	NULL
the	NULL
T-cell	NULL
receptor	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
multiple	NULL
Ets	NULL
family	NULL
members	NULL
with	NULL
apparently	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificities	NULL
regulate	NULL
differential	NULL
gene	NULL
expression	NULL
in	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
ets	NULL
proto-oncogene	NULL
family	NULL
have	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
encode	NULL
transcription	NULL
factors	NULL
that	NULL
interact	NULL
in	NULL
a	NULL
sequence-specific	NULL
manner	NULL
with	NULL
purine-rich	NULL
motifs	NULL
in	NULL
the	NULL
promoters	NULL
and	NULL
enhancers	NULL
of	NULL
several	NULL
viral	NULL
and	NULL
cellular	NULL
genes	NULL
,	NULL
including	NULL
the	NULL
polyomavirus	NULL
enhancer	NULL
(	NULL
55	NULL
)	NULL
,	NULL
the	NULL
Moloney	NULL
sarcoma	NULL
virus	NULL
(	NULL
MSV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
(	NULL
21	NULL
)	NULL
,	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
a-chain	NULL
gene	NULL
enhancer	NULL
(	NULL
23	NULL
)	NULL
,	NULL
and	NULL
the	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
promoter	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Comparisons	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
sites	NULL
of	NULL
ets-/	NULL
and	NULL
two	NULL
Ets-related	NULL
genes	NULL
,	NULL
murine	NULL
PU.1	NULL
and	NULL
Drosophila	NULL
E74	NULL
,	NULL
have	NULL
led	NULL
to	NULL
the	NULL
derivation	NULL
of	NULL
a	NULL
consensus	NULL
sequence	NULL
for	NULL
the	NULL
Ets	NULL
DNA	NULL
binding	NULL
site	NULL
,	NULL
C/AGGAA/T	NULL
(	NULL
30	NULL
)	NULL
.	NULL

By	NULL
using	NULL
this	NULL
consensus	NULL
sequence	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
potential	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
promoter/enhancer	NULL
regions	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
T-cell-specific	NULL
genes	NULL
,	NULL
including	NULL
those	NULL
for	NULL
the	NULL
lymphokines	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
and	NULL
IL-3	NULL
,	NULL
the	NULL
cell	NULL
surface	NULL
receptor	NULL
molecules	NULL
CD2	NULL
,	NULL
CD3	NULL
,	NULL
and	NULL
TCR	NULL
a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
8	NULL
,	NULL
and	NULL
a	NULL
variety	NULL
of	NULL
T-cell-tropic	NULL
viruses	NULL
,	NULL
including	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
(	NULL
HIV-2	NULL
)	NULL
,	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
,	NULL
and	NULL
MSV	NULL
.	NULL

To	NULL
test	NULL
the	NULL
validity	NULL
of	NULL
this	NULL
approach	NULL
for	NULL
identifying	NULL
Ets	NULL
binding	NULL
sites	NULL
and	NULL
to	NULL
better	NULL
understand	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
these	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
regulating	NULL
inducible	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
properties	NULL
of	NULL
the	NULL
two	NULL
predicted	NULL
Ets	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
IL-2	NULL
enhancer	NULL
.	NULL

*	NULL
Corresponding	NULL
author	NULL
.	NULL

The	NULL
IL-2	NULL
gene	NULL
serves	NULL
as	NULL
a	NULL
model	NULL
system	NULL
for	NULL
studies	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
inducible	NULL
gene	NULL
expression	NULL
in	NULL
eukaryotic	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Quiescent	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
TCR	NULL
binding	NULL
of	NULL
an	NULL
antigenic	NULL
peptide	NULL
presented	NULL
in	NULL
association	NULL
with	NULL
a	NULL
self	NULL
major	NULL
histocompatibility	NULL
complex	NULL
molecule	NULL
(	NULL
1	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
resting	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
but	NULL
is	NULL
transcriptionally	NULL
induced	NULL
within	NULL
1	NULL
h	NULL
of	NULL
T-cell	NULL
activation	NULL
(	NULL
12	NULL
,	NULL
14	NULL
,	NULL
34	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
IL-2	NULL
by	NULL
cross-linking	NULL
of	NULL
the	NULL
TCR	NULL
is	NULL
thought	NULL
to	NULL
involve	NULL
at	NULL
least	NULL
two	NULL
signals	NULL
and	NULL
can	NULL
be	NULL
mimicked	NULL
by	NULL
the	NULL
simultaneous	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
increases	NULL
in	NULL
intracellular	NULL
calcium	NULL
levels	NULL
(	NULL
45	NULL
,	NULL
57	NULL
,	NULL
59	NULL
)	NULL
.	NULL

IL-2	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
320-bp	NULL
T-cell-specific	NULL
transcriptional	NULL
enhancer	NULL
that	NULL
is	NULL
located	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
9	NULL
,	NULL
11	NULL
,	NULL
15	NULL
,	NULL
16	NULL
,	NULL
18	NULL
,	NULL
26	NULL
,	NULL
50	NULL
)	NULL
.	NULL

This	NULL
enhancer	NULL
contains	NULL
a	NULL
number	NULL
of	NULL
distinct	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
that	NULL
are	NULL
important	NULL
in	NULL
regulating	NULL
IL-2	NULL
transcription	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
11	NULL
,	NULL
15	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Two	NULL
of	NULL
these	NULL
previously	NULL
defined	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
,	NULL
NFAT-1	NULL
and	NULL
NFIL-2B	NULL
,	NULL
contain	NULL
purine-rich	NULL
sequence	NULL
motifs	NULL
that	NULL
correspond	NULL
to	NULL
the	NULL
consensus	NULL
Ets	NULL
binding	NULL
site	NULL
;	NULL
we	NULL
have	NULL
therefore	NULL
called	NULL
these	NULL
sites	NULL
Ets	NULL
binding	NULL
site	NULL
1	NULL
(	NULL
EBS1	NULL
)	NULL
and	NULL
Ets	NULL
binding	NULL
site	NULL
2	NULL
(	NULL
EBS2	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
the	NULL
studies	NULL
described	NULL
in	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
EBS1	NULL
and	NULL
EBS2	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
NFAT-1	NULL
and	NULL
NFIL-2B	NULL
T	NULL
cell	NULL
nuclear	NULL
protein	NULL
complexes	NULL
and	NULL
are	NULL
required	NULL
for	NULL
inducible	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

Two	NULL
Ets	NULL
family	NULL
members	NULL
,	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
,	NULL
were	NULL
known	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
neither	NULL
of	NULL
these	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
IL-2	NULL
en	NULL
1044	NULL
THOMPSON	NULL
ET	NULL
AL	NULL
.	NULL

hancer	NULL
in	NULL
vitro	NULL
.	NULL

We	NULL
therefore	NULL
used	NULL
low-stringency	NULL
hybridization	NULL
with	NULL
an	NULL
Ets-1	NULL
cDNA	NULL
probe	NULL
to	NULL
screen	NULL
an	NULL
activated	NULL
T-cell	NULL
cDNA	NULL
library	NULL
for	NULL
additional	NULL
Ets-related	NULL
family	NULL
members	NULL
.	NULL

One	NULL
of	NULL
the	NULL
novel	NULL
clones	NULL
identified	NULL
in	NULL
this	NULL
screen	NULL
,	NULL
Elf-1	NULL
,	NULL
was	NULL
found	NULL
to	NULL
bind	NULL
specifically	NULL
to	NULL
both	NULL
of	NULL
the	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
but	NULL
not	NULL
to	NULL
the	NULL
previously	NULL
described	NULL
Ets-1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
TCR	NULL
a	NULL
enhancer	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Elf-1	NULL
was	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
an	NULL
identical	NULL
sequence	NULL
motif	NULL
within	NULL
the	NULL
HIV-2	NULL
enhancer	NULL
that	NULL
is	NULL
required	NULL
for	NULL
inducible	NULL
HIV-2	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
via	NULL
the	NULL
TCR	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
Ets	NULL
proteins	NULL
may	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
multiple	NULL
T-cell	NULL
genes	NULL
and	NULL
that	NULL
different	NULL
Ets	NULL
family	NULL
members	NULL
may	NULL
display	NULL
different	NULL
DNA	NULL
binding	NULL
specificities	NULL
and	NULL
thereby	NULL
differentially	NULL
regulate	NULL
gene	NULL
expression	NULL
during	NULL
both	NULL
T-cell	NULL
development	NULL
and	NULL
activation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
buffy	NULL
coats	NULL
obtained	NULL
by	NULL
leukophore-sis	NULL
of	NULL
healthy	NULL
donors	NULL
age	NULL
21	NULL
to	NULL
31	NULL
years	NULL
by	NULL
using	NULL
density	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Purified	NULL
T	NULL
cells	NULL
were	NULL
then	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
by	NULL
negative	NULL
selection	NULL
using	NULL
immunoabsorption	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Cell	NULL
purification	NULL
was	NULL
routinely	NULL
monitored	NULL
by	NULL
flow	NULL
cytometry	NULL
and	NULL
histochemistry	NULL
.	NULL

Monocytes	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
large	NULL
granular	NULL
lymphocytes	NULL
were	NULL
not	NULL
detectable	NULL
by	NULL
immunofluorescence	NULL
analysis	NULL
.	NULL

Viability	NULL
was	NULL
greater	NULL
than	NULL
99	NULL
%	NULL
as	NULL
measured	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
x	NULL
10°/ml	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
GIBCO	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
N.Y.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
GIBCO	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
G	NULL
per	NULL
ml	NULL
,	NULL
100	NULL
ug	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
15	NULL
mM	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
;	NULL
pH	NULL
7.4	NULL
)	NULL
(	NULL
GIBCO	NULL
)	NULL
.	NULL

Freshly	NULL
isolated	NULL
T	NULL
cells	NULL
were	NULL
activated	NULL
by	NULL
culture	NULL
on	NULL
plates	NULL
coated	NULL
with	NULL
a	NULL
saturating	NULL
quantity	NULL
of	NULL
the	NULL
anti-CD3	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MAb	NULL
)	NULL
G19-4	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
anti-CD28	NULL
MAb	NULL
9.3	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
for	NULL
6	NULL
to	NULL
8	NULL
h	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
28	NULL
)	NULL
or	NULL
by	NULL
treatment	NULL
for	NULL
6	NULL
to	NULL
8	NULL
h	NULL
with	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
ionomycin	NULL
(	NULL
0.4	NULL
pg/ml	NULL
)	NULL
,	NULL
or	NULL
both	NULL
.	NULL

For	NULL
transfection	NULL
experiments	NULL
,	NULL
murine	NULL
EL4	NULL
T-cell	NULL
tumor	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
penicillin-strepto-mycin	NULL
(	NULL
GIBCO	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Plasmids	NULL
.	NULL

The	NULL
pSPCAT	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
minimal	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
promoter	NULL
immediately	NULL
5	NULL
'	NULL
to	NULL
the	NULL
bacterial	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Plasmid	NULL
pIL2CAT	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
IL-2	NULL
promoter/enhancer	NULL
(	NULL
-585	NULL
to	NULL
+18	NULL
)	NULL
immediately	NULL
5	NULL
'	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
,	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Three	NULL
copies	NULL
of	NULL
a	NULL
wild-type	NULL
NFAT-1	NULL
oligonucleotide	NULL
-	NULL
(	NULL
AGAAAGGAGGAAAAACTGTTTCATACAGAAG	NULL
GCGTT	NULL
)	NULL
or	NULL
a	NULL
mutant	NULL
NFAT-1	NULL
oligonucleotide	NULL
(	NULL
AGAAA	NULL
COGTCCTAAAACTGTTTCATACAGAAGGCGTT	NULL
)	NULL
containing	NULL
BamHI-Bg/ll	NULL
overhanging	NULL
ends	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
pSPCAT	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
to	NULL
create	NULL
plasmids	NULL
pSPNFATCAT	NULL
and	NULL
pSPm	NULL
NFATCAT	NULL
.	NULL

Mutations	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
EBS1	NULL
,	NULL
EBS2	NULL
,	NULL
and	NULL
3'NFAT	NULL
sites	NULL
of	NULL
pIL2CAT	NULL
by	NULL
gapped	NULL
heterodu-plex	NULL
oligonucleotide-mediated	NULL
site-directed	NULL
mutagenesis	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
31	NULL
)	NULL
with	NULL
the	NULL
following	NULL
oligonucleo-tides	NULL
:	NULL
mEBS1	NULL
(	NULL
GAAGATCTTCGTCACTGTTTC	NULL
;	NULL
-282	NULL
to	NULL
-261	NULL
)	NULL
,	NULL
mEBS2	NULL
(	NULL
ATCAGACGTCCTAAA	NULL
;	NULL
-137	NULL
to	NULL
-124	NULL
)	NULL
,	NULL
and	NULL
m3'NFAT	NULL
(	NULL
AAATGTGCAGTCTGCAGCGGCGTT	NULL
AAT	NULL
;	NULL
-271	NULL
to	NULL
-245	NULL
)	NULL
.	NULL

All	NULL
mutations	NULL
were	NULL
confirmed	NULL
by	NULL
dideoxy	NULL
DNA	NULL
sequence	NULL
analysis	NULL
.	NULL

The	NULL
pRSVBgal	NULL
reference	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

plasmid	NULL
in	NULL
which	NULL
the	NULL
bacterial	NULL
B-galactosidase	NULL
gene	NULL
is	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
LTR	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

A	NULL
truncated	NULL
version	NULL
of	NULL
the	NULL
human	NULL
Ets-1	NULL
cDNA	NULL
(	NULL
bp	NULL
864	NULL
to	NULL
1347	NULL
)	NULL
containing	NULL
a	NULL
consensus	NULL
eukaryotic	NULL
initiation	NULL
codon	NULL
at	NULL
the	NULL
5°	NULL
end	NULL
was	NULL
prepared	NULL
by	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
,	NULL
using	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
synthetic	NULL
oligonucleotide	NULL
primers	NULL
with	NULL
the	NULL
sequences	NULL
CCAAGCTTG	NULL
GATCCCACCATGGAGGACTATCCGGCTGCCCTGCCC	NULL
and	NULL
CCAAGCTTTCCCCAGCCCCTTCAGTGC	NULL
,	NULL
respectively	NULL
.	NULL

This	NULL
truncated	NULL
cDNA	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
pCDM7	NULL
for	NULL
use	NULL
in	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
reactions	NULL
.	NULL

A	NULL
truncated	NULL
version	NULL
of	NULL
the	NULL
Elf-1	NULL
cDNA	NULL
(	NULL
bp	NULL
312	NULL
to	NULL
1926	NULL
)	NULL
was	NULL
prepared	NULL
by	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
with	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
synthetic	NULL
oligonucleotide	NULL
primers	NULL
consisting	NULL
of	NULL
the	NULL
sequences	NULL
GGGATATCCCACCATGGCTGCTGTTGTC	NULL
CAACAGAAC	NULL
and	NULL
GGGATATCTCACCACAGGTGCAG	NULL
TAGCACTGAAG	NULL
,	NULL
respectively	NULL
.	NULL

This	NULL
truncated	NULL
cDNA	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
EcoRV	NULL
site	NULL
of	NULL
pcDNA1l/neo	NULL
(	NULL
InVitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
for	NULL
use	NULL
in	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
reactions	NULL
.	NULL

Plasmid	NULL
DNA	NULL
for	NULL
use	NULL
in	NULL
transfections	NULL
was	NULL
prepared	NULL
by	NULL
cesium	NULL
chloride	NULL
density	NULL
gradient	NULL
centrifugation	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
cultured	NULL
T	NULL
cells	NULL
by	NULL
centrifugation	NULL
at	NULL
14,000	NULL
x	NULL
g	NULL
for	NULL
2	NULL
min	NULL
following	NULL
cell	NULL
lysis	NULL
with	NULL
40	NULL
mM	NULL
KCI-10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.0	NULL
)	NULL
-3	NULL
mM	NULL
MgCl	NULL
,	NULL
-1	NULL
mM	NULL
dithiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
-S5	NULL
%	NULL
glycerol-8	NULL
pg	NULL
of	NULL
aprotinin	NULL
per	NULL
ml-2	NULL
ug	NULL
of	NULL
leupeptin	NULL
per	NULL
ml-0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
-0.2	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
Noni-det	NULL
P-40	NULL
.	NULL

Nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
-0.42	NULL
M	NULL
KCI-1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
-0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT-0.5	NULL
mM	NULL
PMSF-25	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Extracts	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
at	NULL
14,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
resulting	NULL
supernatants	NULL
were	NULL
dialyzed	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4°C	NULL
against	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
0.1	NULL
M	NULL
KCl	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
20	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
(	NULL
buffer	NULL
D	NULL
)	NULL
and	NULL
frozen	NULL
in	NULL
aliquots	NULL
at	NULL
-70°C	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
,	NULL
The	NULL
following	NULL
double-stranded	NULL
oligonucleotides	NULL
containing	NULL
overhanging	NULL
BamHI-Bgill	NULL
ends	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosys-tems	NULL
model	NULL
380B	NULL
DNA	NULL
synthesizer	NULL
and	NULL
labelled	NULL
with	NULL
*°P-nucleotides	NULL
by	NULL
fill-in	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
prior	NULL
to	NULL
use	NULL
in	NULL
EMSAs	NULL
:	NULL
NFAT	NULL
:	NULL
AGAAAGGAGGAAAAACTGTTTCATACAGAAGGCGTT	NULL
mNFAT	NULL
:	NULL
AGAAACGTCCTAAAACTGTTTCATACAGAAGGCGTT	NULL
IL-2B	NULL
:	NULL
AAAGAGTCATCAGAAGAGGAAAAATGAAGGT	NULL
mIL-2B	NULL
:	NULL
AAAGAGTCATCAGAAGTCCTAAAATGAAGGT	NULL
MSV	NULL
LTR	NULL
:	NULL
TCGGAGAGCGGAAGCGCGC	NULL
Ta2	NULL
:	NULL
CCTCTTCTTTCCAGAGGATGTGGCTTCTGCGA	NULL
Tad	NULL
:	NULL
AGAGATAGCATCGCCCCAGGCCACGTGCCGAGGG	NULL
HIV-2	NULL
LTR	NULL
:	NULL
CCATTTAGTTAAAGACAGGAACAGCTAT	NULL
Binding	NULL
reactions	NULL
using	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
contained	NULL
1	NULL
to	NULL
1.5	NULL
ug	NULL
of	NULL
T-cell	NULL
nuclear	NULL
protein	NULL
,	NULL
20,000	NULL
dpm	NULL
(	NULL
0.1	NULL
to	NULL
0.5	NULL
ng	NULL
)	NULL
of	NULL
radiolabelled	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
250	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
1.25	NULL
mM	NULL
DTT	NULL
,	NULL
1.1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
15	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
in	NULL
a	NULL
final	NULL
reaction	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
.	NULL

Following	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
,	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
on	NULL
nondenaturing	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
at	NULL
100	NULL
V	NULL
for	NULL
2.5	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
TGE	NULL
buffer	NULL
(	NULL
0.05	NULL
M	NULL
Tris	NULL
,	NULL
0.5	NULL
M	NULL
glycine	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
)	NULL
with	NULL
47	NULL
wM	NULL
B-mercaptoethanol	NULL
.	NULL

Binding	NULL
reactions	NULL
using	NULL
1	NULL
wl	NULL
of	NULL
bacterially	NULL
produced	NULL
Elf-1	NULL
protein	NULL
from	NULL
purified	NULL
inclusion	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
bodies	NULL
were	NULL
performed	NULL
identically	NULL
to	NULL
those	NULL
using	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
the	NULL
gels	NULL
were	NULL
run	NULL
at	NULL
110	NULL
V	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Binding	NULL
reactions	NULL
using	NULL
in	NULL
vitro-transcribed	NULL
and	NULL
-translated	NULL
Elf-1	NULL
and	NULL
Ets-1	NULL
proteins	NULL
contained	NULL
3	NULL
pl	NULL
of	NULL
in	NULL
vitro-translated	NULL
protein	NULL
,	NULL
20,000	NULL
dpm	NULL
of	NULL
radiolabelled	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
250	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
75	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
4	NULL
%	NULL
Ficoll	NULL
.	NULL

Following	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
in	NULL
4	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
which	NULL
were	NULL
run	NULL
in	NULL
0.25	NULL
%	NULL
Tris-borate-EDTA	NULL
buffer	NULL
at	NULL
110	NULL
V	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

All	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
subjected	NULL
to	NULL
autora-diography	NULL
using	NULL
intensifying	NULL
screens	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Methylation	NULL
interference	NULL
and	NULL
UV	NULL
cross-linking	NULL
.	NULL

For	NULL
methylation	NULL
interference	NULL
experiments	NULL
,	NULL
an	NULL
NFAT-1	NULL
oligonucleotide	NULL
labelled	NULL
with	NULL
[	NULL
P°PJATP	NULL
by	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
was	NULL
incubated	NULL
with	NULL
dimethylsulfate	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.05	NULL
M	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
resulting	NULL
oligonucleotide	NULL
was	NULL
used	NULL
in	NULL
an	NULL
EMSA	NULL
binding	NULL
reaction	NULL
(	NULL
see	NULL
above	NULL
)	NULL
that	NULL
contained	NULL
2	NULL
x	NULL
10°	NULL
dpm	NULL
of	NULL
radiolabelled	NULL
methylated	NULL
oligonucleotide	NULL
,	NULL
10	NULL
mg	NULL
of	NULL
T-cell	NULL
nuclear	NULL
protein	NULL
,	NULL
and	NULL
1	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
a	NULL
final	NULL
reaction	NULL
volume	NULL
of	NULL
50	NULL
pl	NULL
.	NULL

The	NULL
products	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
4	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Following	NULL
autoradiography	NULL
,	NULL
the	NULL
bound	NULL
and	NULL
free	NULL
probes	NULL
were	NULL
excised	NULL
and	NULL
eluted	NULL
from	NULL
the	NULL
gel	NULL
.	NULL

The	NULL
recovered	NULL
DNA	NULL
was	NULL
cleaved	NULL
with	NULL
1	NULL
M	NULL
piperidine	NULL
at	NULL
90°C	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
on	NULL
a	NULL
standard	NULL
12	NULL
%	NULL
polyacrylamide	NULL
DNA	NULL
sequencing	NULL
gel	NULL
.	NULL

An	NULL
equal	NULL
number	NULL
of	NULL
counts	NULL
was	NULL
loaded	NULL
into	NULL
each	NULL
lane	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

For	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
T-cell	NULL
nuclear	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
10°	NULL
dpm	NULL
of	NULL
radiolabelled	NULL
NFAT-1	NULL
oligonucleotide	NULL
with	NULL
bromodeoxyuridine	NULL
(	NULL
BrdU	NULL
)	NULL
incorporated	NULL
on	NULL
the	NULL
antisense	NULL
strand	NULL
in	NULL
an	NULL
EMSA	NULL
binding	NULL
reaction	NULL
mixture	NULL
containing	NULL
1	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
resulting	NULL
complexes	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
4	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Following	NULL
elec-trophoresis	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
subjected	NULL
to	NULL
UV	NULL
irradiation	NULL
(	NULL
250	NULL
mJ/cm	NULL
)	NULL
,	NULL
using	NULL
a	NULL
Stratalinker	NULL
model	NULL
1800	NULL
apparatus	NULL
(	NULL
Strata-gene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
containing	NULL
a	NULL
254-nm	NULL
source	NULL
.	NULL

Following	NULL
autoradiography	NULL
,	NULL
the	NULL
NFAT-1	NULL
band	NULL
was	NULL
excised	NULL
and	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
fractionated	NULL
directly	NULL
from	NULL
the	NULL
gel	NULL
slice	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
10	NULL
%	NULL
denaturing	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-polyacrylamide	NULL
gel	NULL
(	NULL
1.5	NULL
h	NULL
at	NULL
20	NULL
mA	NULL
plus	NULL
2.5	NULL
h	NULL
at	NULL
30	NULL
mA	NULL
at	NULL
room	NULL
temperature	NULL
)	NULL
.	NULL

Transfections	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

Exponentially	NULL
growing	NULL
cultures	NULL
containing	NULL
10	NULL
``	NULL
EL4	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
pug	NULL
of	NULL
reporter	NULL
plasmid	NULL
and	NULL
2.5	NULL
ug	NULL
of	NULL
the	NULL
pRSVBgal	NULL
reference	NULL
plasmid	NULL
,	NULL
using	NULL
DEAE-dextran	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

At	NULL
36	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
medium	NULL
alone	NULL
or	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
!	NULL
)	NULL

plus	NULL
ionomycin	NULL
(	NULL
1.4	NULL
ug/ml	NULL
)	NULL
for	NULL
12	NULL
h	NULL
prior	NULL
to	NULL
harvesting	NULL
.	NULL

Transfected	NULL
cell	NULL
extracts	NULL
were	NULL
normalized	NULL
for	NULL
protein	NULL
content	NULL
by	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
)	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
Elf-1	NULL
cDNA	NULL
clones	NULL
.	NULL

Elf-1	NULL
cDNA	NULL
clones	NULL
were	NULL
isolated	NULL
by	NULL
screening	NULL
a	NULL
Agt11	NULL
cDNA	NULL
library	NULL
from	NULL
PMA-plus-ionomycin-activated	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
by	NULL
a	NULL
low-stringency	NULL
hybridization	NULL
with	NULL
a	NULL
radiolabelled	NULL
188-bp	NULL
Ball-Aatll	NULL
cDNA	NULL
fragment	NULL
containing	NULL
the	NULL
basic	NULL
domain	NULL
of	NULL
human	NULL
Ets-1	NULL
(	NULL
bp	NULL
1113	NULL
to	NULL
1301	NULL
)	NULL
.	NULL

Final	NULL
washing	NULL
condition	NULL
were	NULL
2	NULL
%	NULL
SSC	NULL
(	NULL
1x	NULL
SSC	NULL
is	NULL
0.15	NULL
M	NULL
NaCl	NULL
plus	NULL
0.015	NULL
sodium	NULL
citrate	NULL
)	NULL
-0.1	NULL
%	NULL
SDS	NULL
at	NULL
50°C	NULL
for	NULL
60	NULL
min	NULL
.	NULL

Elf-1	NULL
cDNAs	NULL
were	NULL
subcloned	NULL
into	NULL
Blue-script	NULL
KS	NULL
for	NULL
restriction	NULL
enzyme	NULL
and	NULL
DNA	NULL
sequence	NULL
analysis	NULL
.	NULL

Dideoxy	NULL
DNA	NULL
sequencing	NULL
reactions	NULL
were	NULL
performed	NULL
by	NULL
Ets	NULL
BINDING	NULL
SITES	NULL
IN	NULL
THE	NULL
IL-2	NULL
ENHANCER	NULL
1045	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
U.S.	NULL
Biochemicals	NULL
,	NULL
Cleveland	NULL
,	NULL
Ohio	NULL
)	NULL
.	NULL

All	NULL
sequence	NULL
was	NULL
obtained	NULL
on	NULL
both	NULL
strands	NULL
.	NULL

To	NULL
obtain	NULL
overlapping	NULL
sequences	NULL
,	NULL
deletional	NULL
clones	NULL
were	NULL
made	NULL
by	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Strata-gene	NULL
)	NULL
.	NULL

DNA	NULL
sequence	NULL
analyses	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
DNASTAR	NULL
(	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
software	NULL
package	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
reactions	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
InVitrogen	NULL
)	NULL
according	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

In	NULL
vitro	NULL
translation	NULL
reactions	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
rabbit	NULL
reticulocyte	NULL
system	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Production	NULL
of	NULL
recombinant	NULL
Elf-1	NULL
protein	NULL
.	NULL

The	NULL
truncated	NULL
Elf-1	NULL
cDNA	NULL
(	NULL
see	NULL
above	NULL
)	NULL
was	NULL
excised	NULL
from	NULL
pcDNAl/neo	NULL
by	NULL
digestion	NULL
with	NULL
EcoRV	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
the	NULL
pET-3b	NULL
vector	NULL
(	NULL
52	NULL
)	NULL
following	NULL
blunting	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
polymerase	NULL
I	NULL
.	NULL

The	NULL
resulting	NULL
plasmid	NULL
was	NULL
transformed	NULL
into	NULL
competent	NULL
Escherichia	NULL
coli	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
,	NULL
and	NULL
a	NULL
single	NULL
colony	NULL
was	NULL
grown	NULL
in	NULL
M9ZB	NULL
medium	NULL
(	NULL
52	NULL
)	NULL
containing	NULL
carbenicillin	NULL
(	NULL
100	NULL
pg/ml	NULL
)	NULL
to	NULL
an	NULL
optical	NULL
density	NULL
at	NULL
600	NULL
nm	NULL
of	NULL
0.5	NULL
.	NULL

(	NULL
IPTG	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
2	NULL
mM	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
grown	NULL
at	NULL
37°C	NULL
for	NULL
2.5	NULL
h	NULL
with	NULL
shaking	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
4,000	NULL
rpm	NULL
in	NULL
a	NULL
microcentrifuge	NULL
(	NULL
Eppendorf	NULL
5415	NULL
)	NULL
and	NULL
lysed	NULL
in	NULL
50	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
-1	NULL
mM	NULL
EDTA-1	NULL
mM	NULL
DTT-1	NULL
mM	NULL
PMSF-260	NULL
ug	NULL
of	NULL
lysozyme	NULL
per	NULL
ml	NULL
.	NULL

Inclusion	NULL
bodies	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
4,000	NULL
rpm	NULL
in	NULL
a	NULL
microcentrifuge	NULL
(	NULL
Eppendorf	NULL
5415	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
denatured	NULL
and	NULL
solubilized	NULL
in	NULL
6	NULL
M	NULL
urea	NULL
and	NULL
then	NULL
renatured	NULL
by	NULL
dialysis	NULL
against	NULL
buffer	NULL
D	NULL
overnight	NULL
at	NULL
4°C	NULL
prior	NULL
to	NULL
freezing	NULL
in	NULL
aliquots	NULL
at	NULL
-70°C	NULL
.	NULL

Control	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
E.	NULL
coli	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
containing	NULL
plasmid	NULL
pET-3b	NULL
without	NULL
a	NULL
cDNA	NULL
insert	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
accession	NULL
number	NULL
.	NULL

The	NULL
complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
Elf-1	NULL
is	NULL
available	NULL
through	NULL
GenBank	NULL
,	NULL
accession	NULL
number	NULL
M82882	NULL
.	NULL

RESULTS	NULL
Two	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
.	NULL

The	NULL
recent	NULL
demonstration	NULL
of	NULL
the	NULL
sequence-specific	NULL
binding	NULL
of	NULL
three	NULL
Ets	NULL
family	NULL
members	NULL
,	NULL
Ets-1	NULL
,	NULL
PU.1	NULL
,	NULL
and	NULL
E74	NULL
,	NULL
has	NULL
allowed	NULL
the	NULL
derivation	NULL
of	NULL
a	NULL
consensus	NULL
Ets	NULL
binding	NULL
sequence	NULL
(	NULL
23	NULL
,	NULL
30	NULL
)	NULL
.	NULL

An	NULL
examination	NULL
of	NULL
known	NULL
T-cell	NULL
promoters	NULL
and	NULL
enhancers	NULL
for	NULL
this	NULL
sequence	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
potential	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
a	NULL
large	NULL
number	NULL
of	NULL
T-cell-associated	NULL
genes	NULL
,	NULL
including	NULL
those	NULL
for	NULL
the	NULL
lymphokines	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
GM-CSF	NULL
,	NULL
the	NULL
cell	NULL
surface	NULL
receptors	NULL
CD2	NULL
,	NULL
CD3	NULL
,	NULL
and	NULL
TCR	NULL
a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
8	NULL
,	NULL
and	NULL
a	NULL
variety	NULL
of	NULL
T-cell-tropic	NULL
viruses	NULL
,	NULL
including	NULL
HIV-2	NULL
,	NULL
HTLV-I	NULL
,	NULL
and	NULL
MSV	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
predicted	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
have	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
Ets-1	NULL
(	NULL
4	NULL
)	NULL
.	NULL

To	NULL
further	NULL
understand	NULL
the	NULL
role	NULL
of	NULL
Ets	NULL
family	NULL
members	NULL
in	NULL
regulating	NULL
inducible	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
properties	NULL
of	NULL
the	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
enhancer	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
320-bp	NULL
IL-2	NULL
enhancer	NULL
revealed	NULL
two	NULL
potential	NULL
Ets	NULL
binding	NULL
sites	NULL
which	NULL
we	NULL
will	NULL
refer	NULL
to	NULL
hereafter	NULL
as	NULL
EBS1	NULL
and	NULL
EBS2	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

EBS1	NULL
is	NULL
located	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
NFAT-1	NULL
DNase	NULL
I	NULL
footprint	NULL
(	NULL
47	NULL
)	NULL
,	NULL
whereas	NULL
EBS2	NULL
is	NULL
contained	NULL
within	NULL
the	NULL
previously	NULL
described	NULL
NFIL-2B	NULL
binding	NULL
site	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
of	NULL
NFAT-1	NULL
have	NULL
suggested	NULL
that	NULL
this	NULL
site	NULL
binds	NULL
a	NULL
T-cell-specific	NULL
nuclear	NULL
protein	NULL
complex	NULL
that	NULL
is	NULL
induced	NULL
in	NULL
T-cell	NULL
tumor	NULL
lines	NULL
following	NULL
stimulation	NULL
with	NULL
phytohemagglutinin	NULL
and	NULL
PMA	NULL
(	NULL
11	NULL
,	NULL
43	NULL
,	NULL
47	NULL
)	NULL
.	NULL

In	NULL
an	NULL
initial	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
nuclear	NULL
extracts	NULL
from	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
1046	NULL
THOMPSON	NULL
ET	NULL
AL	NULL
.	NULL

IL-2	NULL
Enh	NULL
:	NULL
AGCAGGAAAAA	NULL
(	NULL
NFAT-1	NULL
)	NULL
AAGAGQAAAAA	NULL
(	NULL
IL-2B	NULL
)	NULL
GM-CSF	NULL
Pr	NULL
:	NULL
CAGAGGAAATG	NULL
IL-3	NULL
Pr	NULL
:	NULL
cockéekAcra	NULL
TCR	NULL
@	NULL
Enh	NULL
:	NULL
(	NULL
To	NULL
?	NULL
)	NULL

TCR	NULL
B	NULL
Enh	NULL
:	NULL
AACAgéhchG	NULL
(	NULL
TB3	NULL
)	NULL
CD3	NULL
8	NULL
Enh	NULL
:	NULL
TTGAGGATGAG	NULL
CD3	NULL
€	NULL
Enh	NULL
:	NULL
CGCAGGATGTG	NULL
TCR	NULL
8	NULL
Enh	NULL
:	NULL
GAAAGGATTAG	NULL
CD2	NULL
Enh	NULL
:	NULL
CACAGGAAAAA	NULL
MSV	NULL
LTR	NULL
:	NULL
GAGCGGAAGCCG	NULL
HTLV-1	NULL
LTR	NULL
:	NULL
GGGASGAAATCG	NULL
HIV-2	NULL
LTR	NULL
:	NULL
GACAGGAACAG	NULL
(	NULL
CD3R	NULL
)	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Potential	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
T-cell	NULL
genes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
of	NULL
genes	NULL
known	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

The	NULL
IL-2	NULL
enhancer	NULL
sequence	NULL
is	NULL
from	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
,	NULL
the	NULL
GM-CSF	NULL
sequence	NULL
is	NULL
from	NULL
Miyatake	NULL
et	NULL
al	NULL
.	NULL

(	NULL
40	NULL
)	NULL
,	NULL
the	NULL
IL-3	NULL
sequence	NULL
is	NULL
from	NULL
Miyatake	NULL
et	NULL
al	NULL
.	NULL

(	NULL
41	NULL
)	NULL
,	NULL
the	NULL
TCR	NULL
a	NULL
enhancer	NULL
sequence	NULL
is	NULL
from	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
,	NULL
the	NULL
TCR	NULL
B	NULL
enhancer	NULL
sequence	NULL
is	NULL
from	NULL
Gottschalk	NULL
and	NULL
Leiden	NULL
(	NULL
20	NULL
)	NULL
,	NULL
the	NULL
CD36	NULL
enhancer	NULL
sequence	NULL
is	NULL
from	NULL
Georgopoulos	NULL
et	NULL
al	NULL
.	NULL

(	NULL
19	NULL
)	NULL
,	NULL
the	NULL
CD3s	NULL
enhancer	NULL
sequence	NULL
is	NULL
from	NULL
Clevers	NULL
et	NULL
al	NULL
.	NULL

(	NULL
8	NULL
)	NULL
,	NULL
the	NULL
TCR	NULL
8	NULL
enhancer	NULL
sequence	NULL
is	NULL
from	NULL
Redondo	NULL
et	NULL
al	NULL
.	NULL

(	NULL
44	NULL
)	NULL
,	NULL
and	NULL
the	NULL
CD2	NULL
enhancer	NULL
is	NULL
from	NULL
Lake	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
LTRs	NULL
of	NULL
T-cell-tropic	NULL
retroviruses	NULL
.	NULL

The	NULL
MSV	NULL
LTR	NULL
sequence	NULL
is	NULL
from	NULL
Gunther	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
,	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
sequence	NULL
is	NULL
from	NULL
Bosselut	NULL
et	NULL
al	NULL
.	NULL

(	NULL
4	NULL
)	NULL
,	NULL
and	NULL
the	NULL
HIV-2	NULL
LTR	NULL
sequence	NULL
is	NULL
from	NULL
Guyader	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
)	NULL
and	NULL
Markovitz	NULL
et	NULL
al	NULL
.	NULL

(	NULL
38	NULL
)	NULL
.	NULL

activated	NULL
by	NULL
cross-linking	NULL
of	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
also	NULL
contained	NULL
a	NULL
protein	NULL
complex	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
NFAT-1	NULL
oligonucleotide	NULL
probe	NULL
by	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
binding	NULL
activity	NULL
was	NULL
not	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
resting	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
,	NULL
was	NULL
suppressed	NULL
by	NULL
treatment	NULL
with	NULL
cyclosporin	NULL
A	NULL
,	NULL
was	NULL
enhanced	NULL
by	NULL
costimulation	NULL
with	NULL
CD28	NULL
,	NULL
and	NULL
was	NULL
also	NULL
induced	NULL
by	NULL
treatment	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
with	NULL
PMA	NULL
-300	NULL
-200	NULL
-100	NULL
1	NULL
1	NULL
I	NULL
I	NULL
I	NULL
mEBS2	NULL
:	NULL
TCCT	NULL
EBS2	NULL
NFIL-2D	NULL
NFAT-1	NULL
NFIL-2	NULL
NFIL-28	NULL
NFIL-2A	NULL
C	NULL
)	NULL
CDED	NULL
_	NULL
\CO	NULL
CO	NULL
REST	NULL
EHT	NULL
oe	NULL
ate	NULL
o	NULL
0	NULL
t	NULL
Ey	NULL
0	NULL
cy	NULL
yt	NULL
uu	NULL
050	NULL
ott	NULL
u	NULL
IUE	NULL
T.	NULL
EBS1	NULL
Acoftacorccarrarprerrrcaracacaacecert	NULL
mEBS1	NULL
:	NULL
c	NULL
TCCr	NULL
m3'NFAT	NULL
:	NULL
TGTGCAGTCTGCAGC	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
enhancer	NULL
.	NULL

The	NULL
IL-2	NULL
enhancer	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
hatched	NULL
bar	NULL
.	NULL

Nuclear	NULL
protein	NULL
complexes	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
enhancer	NULL
are	NULL
from	NULL
Durand	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
wild-type	NULL
NFAT-1	NULL
and	NULL
NFIL-2B	NULL
sites	NULL
are	NULL
shown	NULL
below	NULL
and	NULL
above	NULL
the	NULL
map	NULL
,	NULL
respectively	NULL
(	NULL
11	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Potential	NULL
Ets	NULL
binding	NULL
sites	NULL
(	NULL
EBS1	NULL
and	NULL
EBS2	NULL
)	NULL
are	NULL
boxed	NULL
and	NULL
labelled	NULL
.	NULL

Nucleotide	NULL
substitutions	NULL
incorporated	NULL
into	NULL
mutant	NULL
NFAT-1	NULL
(	NULL
mEBSl	NULL
and	NULL
m3'NFAT	NULL
)	NULL
and	NULL
NFIL-2B	NULL
(	NULL
mEBS2	NULL
)	NULL
oligonucleotides	NULL
are	NULL
shown	NULL
below	NULL
and	NULL
above	NULL
the	NULL
wild-type	NULL
sequences	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
heavy	NULL
arrow	NULL
represents	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
9	NULL
,	NULL
16	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Nucleotides	NULL
are	NULL
numbered	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
and	NULL
are	NULL
shown	NULL
above	NULL
the	NULL
map	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

C	NULL
s	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

EMSAs	NULL
of	NULL
NFAT-1	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Purified	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
7	NULL
h	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
MED	NULL
)	NULL
or	NULL
in	NULL
tissue	NULL
culture	NULL
dishes	NULL
coated	NULL
with	NULL
an	NULL
anti-CD3	NULL
MAb	NULL
(	NULL
«	NULL
-CD3	NULL
)	NULL
.	NULL

Cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
or	NULL
the	NULL
anti-CD28	NULL
MAb	NULL
9.3	NULL
(	NULL
«	NULL
-CD28	NULL
)	NULL
was	NULL
added	NULL
to	NULL
some	NULL
cultures	NULL
.	NULL

Duplicate	NULL
cultures	NULL
of	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
7	NULL
h	NULL
with	NULL
PMA	NULL
,	NULL
ionomycin	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
as	NULL
indicated	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
these	NULL
cultures	NULL
were	NULL
used	NULL
in	NULL
EMSAs	NULL
with	NULL
a	NULL
radiolabelled	NULL
NFAT-1	NULL
oligonucleotide	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
arrow	NULL
denotes	NULL
the	NULL
band	NULL
of	NULL
altered	NULL
mobility	NULL
corresponding	NULL
to	NULL
the	NULL
previously	NULL
described	NULL
NFAT-1	NULL
complex	NULL
from	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

plus	NULL
ionomycin	NULL
but	NULL
not	NULL
with	NULL
either	NULL
PMA	NULL
or	NULL
ionomycin	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
EBS1	NULL
,	NULL
the	NULL
potential	NULL
Ets	NULL
binding	NULL
site	NULL
in	NULL
NFAT-1	NULL
,	NULL
was	NULL
involved	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
NFAT-1	NULL
nuclear	NULL
protein	NULL
complex	NULL
,	NULL
we	NULL
performed	NULL
methylation	NULL
interference	NULL
experiments	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
anti-CD3-stimulated	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
methylation	NULL
of	NULL
two	NULL
G	NULL
residues	NULL
at	NULL
the	NULL
core	NULL
of	NULL
EBS1	NULL
prevented	NULL
binding	NULL
of	NULL
the	NULL
NFAT-1	NULL
complex	NULL
.	NULL

Methylation	NULL
of	NULL
these	NULL
same	NULL
core	NULL
G	NULL
residues	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
prevent	NULL
binding	NULL
of	NULL
Ets-1	NULL
to	NULL
the	NULL
MSV	NULL
LTR	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
methylation	NULL
of	NULL
at	NULL
least	NULL
one	NULL
G	NULL
residue	NULL
3	NULL
'	NULL
of	NULL
EBS1l	NULL
but	NULL
within	NULL
NFAT-1	NULL
also	NULL
inhibited	NULL
binding	NULL
of	NULL
the	NULL
NFAT-1	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Further	NULL
support	NULL
for	NULL
the	NULL
hypothesis	NULL
that	NULL
NFAT-1	NULL
contains	NULL
a	NULL
functional	NULL
Ets	NULL
binding	NULL
site	NULL
was	NULL
obtained	NULL
from	NULL
EMSAs	NULL
using	NULL
wild-type	NULL
and	NULL
mutated	NULL
NFAT-1	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
demonstrated	NULL
that	NULL
NFAT-1	NULL
binding	NULL
could	NULL
be	NULL
inhibited	NULL
efficiently	NULL
by	NULL
unlabelled	NULL
wild-type	NULL
NFAT-1	NULL
competitor	NULL
oligonucleotides	NULL
but	NULL
not	NULL
by	NULL
a	NULL
mutant	NULL
NFAT-1	NULL
competitor	NULL
(	NULL
mNFAT-1	NULL
)	NULL
containing	NULL
nucleotide	NULL
substitutions	NULL
within	NULL
the	NULL
EBS1	NULL
core	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
for	NULL
mutations	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
NFAT-1	NULL
could	NULL
also	NULL
be	NULL
competed	NULL
for	NULL
efficiently	NULL
by	NULL
an	NULL
unlabelled	NULL
IL-2B	NULL
competitor	NULL
oligonucleotide	NULL
but	NULL
not	NULL
by	NULL
a	NULL
mutant	NULL
IL-2B	NULL
competitor	NULL
(	NULL
mIL-2B	NULL
)	NULL
in	NULL
which	NULL
the	NULL
core	NULL
of	NULL
EBS2	NULL
(	NULL
AGGA	NULL
)	NULL
was	NULL
inverted	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
low-level	NULL
competition	NULL
seen	NULL
with	NULL
the	NULL
mIL-2B	NULL
compet-itor	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
sequence	NULL
TTAGGACT	NULL
on	NULL
the	NULL
antisense	NULL
strand	NULL
,	NULL
suggests	NULL
that	NULL
more	NULL
than	NULL
the	NULL
conserved	NULL
AGGA	NULL
in	NULL
the	NULL
ETS	NULL
binding	NULL
site	NULL
core	NULL
is	NULL
necessary	NULL
for	NULL
binding	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
G	NULL
G	NULL
A	NULL
A	NULL
2	NULL
_	NULL
%	NULL
o\	NULL
£3	NULL
?	NULL

A	NULL
C	NULL
&	NULL
o	NULL
LL	NULL
¢	NULL
e	NULL
io	NULL
b	NULL
C	NULL
T	NULL
T	NULL
T	NULL
OG/	NULL
T	NULL
_C	NULL
,	NULL
A	NULL
A	NULL
h	NULL
A	NULL
A	NULL
A	NULL
+G	NULL
e	NULL
[	NULL
p	NULL
>	NULL
»	NULL
?	NULL

0	NULL
0	NULL
>	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Methylation	NULL
interference	NULL
analysis	NULL
of	NULL
the	NULL
NFAT-1	NULL
nuclear	NULL
protein	NULL
complex	NULL
.	NULL

Partially	NULL
methylated	NULL
,	NULL
radiolabelled	NULL
NFAT-1	NULL
oligonucleotide	NULL
was	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
control	NULL
probe	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
anti-CD3	NULL
MAb-treated	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
.	NULL

Bound	NULL
and	NULL
free	NULL
probes	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
4	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
cleaved	NULL
with	NULL
piperidine	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
NFAT-1	NULL
oligonucleotide	NULL
is	NULL
shown	NULL
at	NULL
the	NULL
left	NULL
(	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
sequence	NULL
is	NULL
at	NULL
the	NULL
bottom	NULL
)	NULL
.	NULL

The	NULL
putative	NULL
Ets	NULL
binding	NULL
site	NULL
(	NULL
EBS1	NULL
)	NULL
is	NULL
boxed	NULL
.	NULL

G	NULL
residues	NULL
protected	NULL
from	NULL
cleavage	NULL
by	NULL
NFAT-1	NULL
binding	NULL
are	NULL
dotted	NULL
.	NULL

A	NULL
NFAT	NULL
IL-2B	NULL
Competitor	NULL
:	NULL
-	NULL
NFAT	NULL
mEBS1	NULL
IL-2B8	NULL
mEBS2	NULL
To3	NULL
nb	NULL
sb	NULL
ab	NULL
ab	NULL
ab	NULL
-o	NULL
«	NULL
6	NULL
-o	NULL
1	NULL
%	NULL
(	NULL
n	NULL
@	NULL
-	NULL
>	NULL
%	NULL
¥	NULL
#	NULL
¥	NULL
-	NULL
CHW	NULL
we	NULL
«	NULL
=	NULL
#	NULL
#	NULL
#	NULL
B	NULL
a	NULL
>	NULL
ae	NULL
Ets	NULL
BINDING	NULL
SITES	NULL
IN	NULL
THE	NULL
IL-2	NULL
ENHANCER	NULL
1047	NULL
of	NULL
the	NULL
NFAT-1	NULL
complex	NULL
.	NULL

More	NULL
extensive	NULL
mutations	NULL
of	NULL
EBS2	NULL
abolished	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
oligonucleotide	NULL
to	NULL
compete	NULL
for	NULL
NFAT-1	NULL
binding	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NFAT-1	NULL
binding	NULL
was	NULL
also	NULL
not	NULL
inhibited	NULL
by	NULL
the	NULL
unrelated	NULL
Ta3	NULL
competitor	NULL
oligonucleotide	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggested	NULL
that	NULL
both	NULL
EBS1	NULL
and	NULL
EBS2	NULL
represent	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
and	NULL
that	NULL
EBS1	NULL
is	NULL
required	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
NFAT-1	NULL
nuclear	NULL
protein	NULL
complex	NULL
.	NULL

NFAT-1	NULL
contains	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
a	NULL
second	NULL
non-Ets	NULL
nuclear	NULL
protein	NULL
.	NULL

The	NULL
methylation	NULL
interference	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
suggested	NULL
that	NULL
G	NULL
residues	NULL
3	NULL
'	NULL
of	NULL
EBS1	NULL
also	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
NFAT-1	NULL
complex	NULL
.	NULL

This	NULL
result	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
NFAT-1	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
two	NULL
distinct	NULL
nuclear	NULL
proteins	NULL
.	NULL

To	NULL
examine	NULL
this	NULL
possibility	NULL
more	NULL
directly	NULL
,	NULL
we	NULL
performed	NULL
UV	NULL
cross-linking	NULL
of	NULL
the	NULL
NFAT-1	NULL
nuclear	NULL
protein	NULL
complex	NULL
to	NULL
a	NULL
BrdU-substituted	NULL
NFAT-1	NULL
oligonucleotide	NULL
probe	NULL
and	NULL
analyzed	NULL
the	NULL
resulting	NULL
products	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
major	NULL
cross-linked	NULL
bands	NULL
with	NULL
sizes	NULL
of	NULL
approximately	NULL
98	NULL
and	NULL
69	NULL
kDa	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
minor	NULL
band	NULL
of	NULL
82	NULL
kDa	NULL
was	NULL
observed	NULL
in	NULL
some	NULL
experiments	NULL
.	NULL

Analysis	NULL
of	NULL
UV	NULL
cross-linking	NULL
of	NULL
the	NULL
BrdU-substituted	NULL
NFAT-1	NULL
oligonucleotide	NULL
probe	NULL
in	NULL
the	NULL
nonspecific	NULL
DNA	NULL
complex	NULL
from	NULL
the	NULL
same	NULL
gel	NULL
failed	NULL
to	NULL
demonstrate	NULL
cross-linking	NULL
to	NULL
any	NULL
proteins	NULL
in	NULL
the	NULL
size	NULL
range	NULL
of	NULL
69	NULL
to	NULL
98	NULL
kDa	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
NFAT-1	NULL
nuclear	NULL
protein	NULL
complex	NULL
contains	NULL
at	NULL
least	NULL
two	NULL
proteins	NULL
,	NULL
one	NULL
of	NULL
which	NULL
is	NULL
an	NULL
Ets	NULL
family	NULL
member	NULL
that	NULL
binds	NULL
to	NULL
EBS1	NULL
and	NULL
the	NULL
second	NULL
of	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
3'NFAT	NULL
sequence	NULL
located	NULL
immediately	NULL
3	NULL
'	NULL
of	NULL
EBS1	NULL
.	NULL

Functional	NULL
significance	NULL
of	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
NFAT-1	NULL
oligonucleotides	NULL
can	NULL
confer	NULL
T-cell-activating	NULL
properties	NULL
on	NULL
a	NULL
reporter	NULL
gene	NULL
when	NULL
oligomerized	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
promoter	NULL
(	NULL
11	NULL
,	NULL
47	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
importance	NULL
of	NULL
EBS1	NULL
for	NULL
NFAT-1	NULL
function	NULL
,	NULL
we	NULL
produced	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
in	NULL
which	NULL
three	NULL
copies	NULL
of	NULL
a	NULL
wild-type	NULL
NFAT-1	NULL
oligonucleotide	NULL
or	NULL
a	NULL
mutant	NULL
NFAT-1	NULL
oligonucleotide	NULL
(	NULL
mNFAT-1	NULL
)	NULL
containing	NULL
nucleotide	NULL
substitutions	NULL
within	NULL
EBS1	NULL
were	NULL
cloned	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
SV40	NULL
promoter/CAT	NULL
transcription	NULL
unit	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
murine	NULL
EL4	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
transfected	NULL
cultures	NULL
were	NULL
divided	NULL
into	NULL
two	NULL
portions	NULL
;	NULL
one	NULL
was	NULL
left	NULL
unstimulated	NULL
,	NULL
and	NULL
the	NULL
second	NULL
was	NULL
activated	NULL
by	NULL
IL-2B	NULL
Competitor	NULL
:	NULL
_	NULL
-	NULL
_NFAT	NULL
IL-2B	NULL
__	NULL
mEBS2	NULL
Ta2	NULL
To3	NULL
(	NULL
ng	NULL
)	NULL
L	NULL
's	NULL
6	NULL
|	NULL
At	NULL
#	NULL
6	NULL
@	NULL
b	NULL
64	NULL
6	NULL
b	NULL
6	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

EMSAs	NULL
of	NULL
NFAT-1	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
radiolabelled	NULL
NFAT-1	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
anti-CD3	NULL
MAb-treated	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
specified	NULL
amounts	NULL
of	NULL
cold-competitor	NULL
oligonucleotides	NULL
.	NULL

The	NULL
specific	NULL
NFAT-1	NULL
complex	NULL
is	NULL
shown	NULL
with	NULL
an	NULL
arrow	NULL
.	NULL

1048	NULL
THOMPSON	NULL
ET	NULL
AL	NULL
.	NULL

$	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

UV	NULL
cross-linking	NULL
of	NULL
the	NULL
NFAT-1	NULL
complex	NULL
.	NULL

A	NULL
radiola-belled	NULL
,	NULL
BrdU-substituted	NULL
NFAT-1	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extract	NULL
from	NULL
anti-CD3	NULL
MAb-treated	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
complexes	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
4	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Following	NULL
UV	NULL
cross-linking	NULL
,	NULL
the	NULL
NFAT-1	NULL
band	NULL
(	NULL
heavy	NULL
arrow	NULL
)	NULL
was	NULL
excised	NULL
from	NULL
the	NULL
EMSA	NULL
gel	NULL
and	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
fractionated	NULL
directly	NULL
from	NULL
the	NULL
gel	NULL
slice	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
10	NULL
%	NULL
denaturing	NULL
SDS-polyacrylamide	NULL
gel	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
.	NULL

Solid	NULL
arrows	NULL
on	NULL
the	NULL
left	NULL
of	NULL
the	NULL
SDS-PAGE	NULL
autoradiogram	NULL
correspond	NULL
to	NULL
the	NULL
major	NULL
UV	NULL
cross-linked	NULL
bands	NULL
of	NULL
98	NULL
and	NULL
69	NULL
kDa	NULL
.	NULL

The	NULL
dotted	NULL
arrow	NULL
represents	NULL
a	NULL
faint	NULL
band	NULL
of	NULL
82	NULL
kDa	NULL
that	NULL
was	NULL
seen	NULL
in	NULL
some	NULL
experiments	NULL
.	NULL

Size	NULL
markers	NULL
in	NULL
kilodaltons	NULL
are	NULL
shown	NULL
at	NULL
the	NULL
right	NULL
.	NULL

treatment	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

Transfections	NULL
of	NULL
EL4	NULL
with	NULL
a	NULL
control	NULL
plasmid	NULL
containing	NULL
the	NULL
SV40	NULL
promoter/CAT	NULL
cassette	NULL
but	NULL
lacking	NULL
the	NULL
NFAT-1	NULL
oligonucleotides	NULL
produced	NULL
low	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
that	NULL
were	NULL
not	NULL
increased	NULL
by	NULL
treatment	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
inclusion	NULL
of	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
NFAT-1	NULL
oligonucleotide	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
transcription	NULL
unit	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
basal	NULL
levels	NULL
of	NULL
CAT	NULL
expression	NULL
but	NULL
did	NULL
lead	NULL
to	NULL
an	NULL
eightfold	NULL
induction	NULL
following	NULL
stimulation	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
EBS1	NULL
sites	NULL
completely	NULL
abolished	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
plasmid	NULL
during	NULL
T-cell	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
EBS1	NULL
site	NULL
is	NULL
required	NULL
both	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
NFAT-1	NULL
complex	NULL
,	NULL
as	NULL
assayed	NULL
by	NULL
EMSA	NULL
and	NULL
methylation	NULL
interfer-ence	NULL
,	NULL
and	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
NFAT-1	NULL
oligonucleotide	NULL
,	NULL
as	NULL
measured	NULL
in	NULL
transient	NULL
transfections	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
EBS1	NULL
,	NULL
EBS2	NULL
,	NULL
and	NULL
3'NFAT	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
function	NULL
of	NULL
the	NULL
native	NULL
IL-2	NULL
enhancer	NULL
,	NULL
we	NULL
introduced	NULL
mutations	NULL
of	NULL
these	NULL
sites	NULL
into	NULL
a	NULL
reporter	NULL
plasmid	NULL
in	NULL
which	NULL
CAT	NULL
expression	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
intact	NULL
585-bp	NULL
IL-2	NULL
enhancer/promoter	NULL
.	NULL

The	NULL
resultant	NULL
plasmids	NULL
were	NULL
then	NULL
transfected	NULL
into	NULL
EL4	NULL
cells	NULL
.	NULL

One	NULL
half	NULL
of	NULL
each	NULL
transfected	NULL
culture	NULL
was	NULL
left	NULL
unstimulated	NULL
,	NULL
and	NULL
the	NULL
other	NULL
half	NULL
was	NULL
treated	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
the	NULL
wild-type	NULL
enhancer	NULL
was	NULL
relatively	NULL
inactive	NULL
in	NULL
untreated	NULL
EL4	NULL
cells	NULL
but	NULL
was	NULL
induced	NULL
at	NULL
least	NULL
100-fold	NULL
following	NULL
treatment	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
EBS1	NULL
or	NULL
EBS2	NULL
had	NULL
relatively	NULL
small	NULL
effects	NULL
on	NULL
inducibility	NULL
(	NULL
35	NULL
or	NULL
53	NULL
%	NULL
reduction	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
3'NFAT	NULL
site	NULL
alone	NULL
also	NULL
produced	NULL
a	NULL
significant	NULL
but	NULL
incomplete	NULL
decrease	NULL
in	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
both	NULL
EBS1l	NULL
and	NULL
EBS2	NULL
completely	NULL
abolished	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
induc-	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

ible	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
enhancer	NULL
requires	NULL
either	NULL
EBS1	NULL
or	NULL
EBS2	NULL
but	NULL
not	NULL
both	NULL
.	NULL

A	NULL
novel	NULL
Ets	NULL
family	NULL
member	NULL
that	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
IL-2	NULL
enhancer	NULL
.	NULL

Two	NULL
highly	NULL
related	NULL
Ets	NULL
family	NULL
members	NULL
,	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
,	NULL
are	NULL
known	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Several	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
whether	NULL
either	NULL
of	NULL
these	NULL
proteins	NULL
is	NULL
a	NULL
constituent	NULL
of	NULL
the	NULL
NFAT-1	NULL
nuclear	NULL
protein	NULL
complex	NULL
.	NULL

First	NULL
,	NULL
Ets-1-	NULL
and	NULL
Ets-2-specific	NULL
antibodies	NULL
were	NULL
used	NULL
in	NULL
shift-shift	NULL
experiments	NULL
with	NULL
a	NULL
radiolabelled	NULL
NFAT-1	NULL
probe	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
activated	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Neither	NULL
of	NULL
these	NULL
antibodies	NULL
had	NULL
a	NULL
specific	NULL
effect	NULL
on	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
NFAT-1	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
a	NULL
second	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
in	NULL
vitro-transcribed	NULL
and	NULL
-translated	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
proteins	NULL
were	NULL
used	NULL
in	NULL
EMSAs	NULL
with	NULL
a	NULL
radiolabelled	NULL
NFAT-1	NULL
probe	NULL
.	NULL

While	NULL
both	NULL
proteins	NULL
were	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
Ets	NULL
binding	NULL
sites	NULL
from	NULL
the	NULL
MSV	NULL
LTR	NULL
and	NULL
the	NULL
human	NULL
TCR	NULL
a	NULL
enhancer	NULL
,	NULL
neither	NULL
protein	NULL
bound	NULL
to	NULL
the	NULL
NFAT-1	NULL
oligonucleotide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
;	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
previously	NULL
defined	NULL
Ets-1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
human	NULL
TCR	NULL
a	NULL
enhancer	NULL
(	NULL
Ta2	NULL
)	NULL
was	NULL
a	NULL
poor	NULL
competitor	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
NFAT-1	NULL
nuclear	NULL
protein	NULL
complex	NULL
to	NULL
the	NULL
IL-2	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
EBS1	NULL
and	NULL
EBS2	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
might	NULL
not	NULL
correspond	NULL
to	NULL
Ets	NULL
proteins	NULL
.	NULL

Alternatively	NULL
,	NULL
these	NULL
proteins	NULL
might	NULL
represent	NULL
novel	NULL
members	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
with	NULL
binding	NULL
specificities	NULL
that	NULL
are	NULL
distinct	NULL
from	NULL
those	NULL
of	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
.	NULL

To	NULL
test	NULL
this	NULL
second	NULL
hypothesis	NULL
,	NULL
we	NULL
screened	NULL
a	NULL
cDNA	NULL
library	NULL
prepared	NULL
from	NULL
PMA-plus-ionomycin-activated	NULL
Jurkat	NULL
T	NULL
cells	NULL
by	NULL
low-stringency	NULL
hybridization	NULL
with	NULL
a	NULL
cDNA	NULL
probe	NULL
from	NULL
the	NULL
COOH-terminal	NULL
basic	NULL
domain	NULL
of	NULL
Ets-1	NULL
,	NULL
a	NULL
region	NULL
that	NULL
is	NULL
highly	NULL
conserved	NULL
in	NULL
all	NULL
Ets	NULL
family	NULL
members	NULL
(	NULL
30	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
resulted	NULL
in	NULL
the	NULL
isolation	NULL
of	NULL
a	NULL
cDNA	NULL
clone	NULL
whose	NULL
Ets	NULL
domain	NULL
shared	NULL
only	NULL
45	NULL
of	NULL
86	NULL
amino	NULL
acids	NULL
with	NULL
the	NULL
Ets	NULL
domain	NULL
of	NULL
either	NULL
Ets-1	NULL
or	NULL
Ets-2	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
Ets	NULL
domain	NULL
of	NULL
this	NULL
clone	NULL
was	NULL
nearly	NULL
identical	NULL
to	NULL
the	NULL
inducible	NULL
Drosophila	NULL
transcription	NULL
factor	NULL
E74	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
whose	NULL
binding	NULL
specificity	NULL
was	NULL
used	NULL
to	NULL
arrive	NULL
at	NULL
a	NULL
consensus	NULL
Ets	NULL
family	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

We	NULL
named	NULL
this	NULL
clone	NULL
Elf-1	NULL
,	NULL
for	NULL
E74-like	NULL
factor	NULL
1	NULL
.	NULL

DNA	NULL
sequence	NULL
analysis	NULL
of	NULL
a	NULL
3.6-kb	NULL
Elf-1	NULL
cDNA	NULL
revealed	NULL
a	NULL
315-bp	NULL
5'°	NULL
untranslated	NULL
region	NULL
,	NULL
a	NULL
single	NULL
long	NULL
open	NULL
reading	NULL
frame	NULL
(	NULL
ORF	NULL
)	NULL
of	NULL
1,857	NULL
bp	NULL
,	NULL
and	NULL
a	NULL
1,392-bp	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
.	NULL

There	NULL
is	NULL
a	NULL
consensus	NULL
polyadenylation	NULL
signal	NULL
(	NULL
AATAAA	NULL
)	NULL
beginning	NULL
at	NULL
bp	NULL
3548	NULL
,	NULL
16	NULL
bp	NULL
before	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
clone	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
size	NULL
of	NULL
this	NULL
cDNA	NULL
corresponds	NULL
to	NULL
the	NULL
size	NULL
of	NULL
the	NULL
predominant	NULL
mRNA	NULL
as	NULL
determined	NULL
by	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
blot	NULL
analyses	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
Elf-1	NULL
mRNA	NULL
is	NULL
expressed	NULL
as	NULL
a	NULL
3.8-kb	NULL
mRNA	NULL
species	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Elf-1	NULL
mRNA	NULL
is	NULL
expressed	NULL
in	NULL
quiescent	NULL
T	NULL
cells	NULL
and	NULL
does	NULL
not	NULL
undergo	NULL
significant	NULL
alteration	NULL
following	NULL
T-cell	NULL
activation	NULL
.	NULL

The	NULL
Elf-1	NULL
ORF	NULL
is	NULL
initiated	NULL
by	NULL
an	NULL
ATG	NULL
at	NULL
bp	NULL
316	NULL
(	NULL
TTAT	NULL
TATGG	NULL
)	NULL
that	NULL
conforms	NULL
with	NULL
the	NULL
consensus	NULL
initiation	NULL
sequence	NULL
of	NULL
Kozak	NULL
(	NULL
33	NULL
)	NULL
.	NULL

This	NULL
ATG	NULL
is	NULL
preceded	NULL
by	NULL
multiple	NULL
termination	NULL
codons	NULL
in	NULL
all	NULL
three	NULL
ORFs	NULL
,	NULL
including	NULL
an	NULL
in-frame	NULL
termination	NULL
codon	NULL
at	NULL
bp	NULL
298	NULL
.	NULL

The	NULL
Elf-1	NULL
ORF	NULL
encodes	NULL
a	NULL
619-amino-acid	NULL
polypeptide	NULL
with	NULL
a	NULL
predicted	NULL
size	NULL
of	NULL
68	NULL
kDa	NULL
.	NULL

The	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
Elf-1	NULL
contains	NULL
a	NULL
basic	NULL
domain	NULL
that	NULL
is	NULL
related	NULL
to	NULL
those	NULL
of	NULL
the	NULL
other	NULL
Ets	NULL
family	NULL
members	NULL
as	NULL
well	NULL
as	NULL
an	NULL
a-helical	NULL
domain	NULL
immediately	NULL
5	NULL
'	NULL
of	NULL
the	NULL
basic	NULL
region	NULL
that	NULL
is	NULL
also	NULL
conserved	NULL
in	NULL
most	NULL
of	NULL
the	NULL
other	NULL
previously	NULL
described	NULL
Ets	NULL
proteins	NULL
.	NULL

Additional	NULL
noteworthy	NULL
features	NULL
of	NULL
the	NULL
Elf-1	NULL
protein	NULL
include	NULL
a	NULL
highly	NULL
acidic	NULL
region	NULL
(	NULL
20	NULL
of	NULL
46	NULL
amino	NULL
acids	NULL
)	NULL
at	NULL
the	NULL
NH	NULL
,	NULL
terminus	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
amino	NULL
acids	NULL
55	NULL
to	NULL
100	NULL
)	NULL
.	NULL

Such	NULL
acidic	NULL
domains	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
function	NULL
as	NULL
transcriptional	NULL
activator	NULL
domains	NULL
in	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Elf-1	NULL
also	NULL
contains	NULL
a	NULL
serine/threonine-	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
Ets	NULL
BINDING	NULL
SITES	NULL
IN	NULL
THE	NULL
IL-2	NULL
ENHANCER	NULL
1049	NULL
Relative	NULL
Cat	NULL
A	NULL
PMA	NULL
+	NULL
lonomycin	NULL
eAactliﬁry	NULL
=	NULL
1	NULL
[	NULL
eer	NULL
en	NULL
]	NULL
[	NULL
cant	NULL
paar	NULL
|	NULL
vam	NULL
|	NULL
_	NULL
our	NULL
_|	NULL
+	NULL
s	NULL
€	NULL
CAT	NULL
CAT	NULL
mEBS1	NULL
{	NULL
3NFAT	NULL
|	NULL
mEBS1	NULL
|	NULL
NFAT	NULL
|	NULL
mEBS1	NULL
+	NULL
6	NULL
a	NULL
6	NULL
6	NULL
|	NULL
po	NULL
B	NULL
PMA	NULL
+	NULL
lonomycin	NULL
IL-2	NULL
Pr/€nh	NULL
-_	NULL
_	NULL
TesTrea	NULL
]	NULL
Tese	NULL
]	NULL
_|	NULL
or	NULL
|	NULL
_	NULL
|	NULL
L+	NULL
-	NULL
w	NULL
5	NULL
-	NULL
<	NULL
[	NULL
~-	NULL
Jressifaen	NULL
|	NULL
__Jes	NULL
[	NULL
__|	NULL
or	NULL
aia	NULL
|	NULL
L	NULL
+	NULL
<	NULL
#	NULL
<	NULL
@	NULL
(	NULL
=	NULL
<	NULL
<	NULL
[	NULL
~-	NULL
Tes	NULL
reefs	NULL
]	NULL
_-	NULL
{	NULL
o	NULL
]	NULL
Soane	NULL
|	NULL
|	NULL
.	NULL

oun	NULL
..	NULL
dH	NULL
[	NULL
-	NULL
<	NULL
<	NULL
[	NULL
~	NULL
[	NULL
o	NULL
|	NULL
sa	NULL
L	NULL
+o	NULL
s	NULL
<	NULL
@	NULL
==	NULL
C	NULL
S-	NULL
[	NULL
md	NULL
+	NULL
,	NULL
‘	NULL
®	NULL
©	NULL
&	NULL
LJ	NULL
100	NULL
120	NULL
140	NULL
Fold	NULL
Induction	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Functional	NULL
significance	NULL
of	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
enhancer	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Three	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
NFAT-1	NULL
oligonucleotide	NULL
or	NULL
a	NULL
mutant	NULL
NFAT	NULL
oligonucleotide	NULL
containing	NULL
nucleotide	NULL
substitutions	NULL
in	NULL
EBS1	NULL
(	NULL
mEBS1	NULL
;	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
were	NULL
cloned	NULL
directly	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
SV40	NULL
promoter	NULL
(	NULL
SV40Pr	NULL
)	NULL
and	NULL
the	NULL
bacterial	NULL
CAT	NULL
gene	NULL
in	NULL
pSPCAT	NULL
as	NULL
shown	NULL
schematically	NULL
at	NULL
the	NULL
left	NULL
.	NULL

Following	NULL
transfection	NULL
into	NULL
EL4	NULL
T	NULL
cells	NULL
,	NULL
one	NULL
half	NULL
of	NULL
the	NULL
transfected	NULL
cultures	NULL
was	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
-	NULL
)	NULL
and	NULL
the	NULL
other	NULL
half	NULL
was	NULL
treated	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
+	NULL
)	NULL
for	NULL
12	NULL
h.	NULL
To	NULL
correct	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiencies	NULL
,	NULL
all	NULL
transfection	NULL
mixtures	NULL
also	NULL
contained	NULL
2.5	NULL
ug	NULL
of	NULL
the	NULL
pRSVRB-gal	NULL
reference	NULL
plasmid	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EL4	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
as	NULL
described	NULL
for	NULL
panel	NULL
A	NULL
with	NULL
plasmid	NULL
pIL-2CAT	NULL
,	NULL
in	NULL
which	NULL
transcription	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
is	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
585-bp	NULL
wild-type	NULL
IL-2	NULL
promoter	NULL
and	NULL
enhancer	NULL
(	NULL
IL-2Pr/Enh	NULL
)	NULL
or	NULL
equal	NULL
amounts	NULL
of	NULL
plasmids	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
EBS1	NULL
(	NULL
mEBS1	NULL
)	NULL
,	NULL
EBS2	NULL
(	NULL
mEBS2	NULL
)	NULL
,	NULL
or	NULL
3'NFAT	NULL
(	NULL
m3	NULL
'	NULL
NFAT	NULL
)	NULL
sequence	NULL
.	NULL

As	NULL
described	NULL
for	NULL
panel	NULL
A	NULL
,	NULL
all	NULL
transfection	NULL
mixtures	NULL
also	NULL
contained	NULL
2.5	NULL
ug	NULL
of	NULL
the	NULL
pRSVB-gal	NULL
reference	NULL
plasmid	NULL
.	NULL

Portions	NULL
of	NULL
the	NULL
transfected	NULL
cultures	NULL
were	NULL
treated	NULL
for	NULL
12	NULL
h	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
+	NULL
)	NULL
,	NULL
and	NULL
cell	NULL
extracts	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

Fold	NULL
induction	NULL
represents	NULL
CAT	NULL
activity	NULL
from	NULL
the	NULL
PMA-plus-ionomycin-treated	NULL
culture/CAT	NULL
activity	NULL
from	NULL
the	NULL
untreated	NULL
culture	NULL
following	NULL
corrections	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiencies	NULL
.	NULL

rich	NULL
region	NULL
immediately	NULL
COOH	NULL
terminal	NULL
to	NULL
the	NULL
basic	NULL
domain	NULL
.	NULL

Ets-1	NULL
and	NULL
Ets-2	NULL
have	NULL
both	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
phosphorylated	NULL
during	NULL
the	NULL
process	NULL
of	NULL
normal	NULL
T-cell	NULL
activation	NULL
(	NULL
17	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
this	NULL
domain	NULL
of	NULL
Elf-1	NULL
might	NULL
also	NULL
undergo	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
specific	NULL
extracellular	NULL
signals	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

ElK-1	NULL
binds	NULL
to	NULL
the	NULL
EBS	NULL
elements	NULL
in	NULL
NFAT-1	NULL
and	NULL
IL-2B	NULL
.	NULL

We	NULL
reasoned	NULL
that	NULL
the	NULL
high	NULL
level	NULL
of	NULL
sequence	NULL
identity	NULL
between	NULL
the	NULL
basic	NULL
domains	NULL
of	NULL
Elf-1	NULL
and	NULL
E74	NULL
might	NULL
result	NULL
in	NULL
similar	NULL
DNA	NULL
binding	NULL
specificities	NULL
.	NULL

Urness	NULL
and	NULL
Thummel	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
E74	NULL
can	NULL
bind	NULL
the	NULL
sequence	NULL
ACGAATCAGG	NULL
AAAACTG	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
core	NULL
sequence	NULL
that	NULL
is	NULL
identical	NULL
to	NULL
those	NULL
of	NULL
EBS1	NULL
and	NULL
EBS2	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
tested	NULL
Elf-1	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
EBS1	NULL
or	NULL
EBS2	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
.	NULL

We	NULL
performed	NULL
a	NULL
series	NULL
of	NULL
EMSAs	NULL
using	NULL
in	NULL
vitro-transcribed	NULL
and	NULL
translated	NULL
and	NULL
recombinant	NULL
Elf-1	NULL
protein	NULL
and	NULL
a	NULL
radiolabelled	NULL
NFAT-1	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

In	NULL
vitro-transcribed	NULL
and	NULL
-translated	NULL
and	NULL
recombinant	NULL
Elf-1	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
NFAT-1	NULL
,	NULL
IL-2B	NULL
,	NULL
and	NULL
MSV	NULL
LTR	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
Elf-1	NULL
to	NULL
NFAT-1	NULL
was	NULL
specific	NULL
for	NULL
the	NULL
EBS1	NULL
sequence	NULL
because	NULL
Elf-1	NULL
failed	NULL
to	NULL
bind	NULL
to	NULL
a	NULL
mutant	NULL
NFAT-1	NULL
(	NULL
mNFAT	NULL
)	NULL
oligonucleotide	NULL
containing	NULL
nucleotide	NULL
substitu-	NULL
tions	NULL
within	NULL
EBS1	NULL
or	NULL
to	NULL
the	NULL
unrelated	NULL
Ta3	NULL
oligonucleotide	NULL
.	NULL

Similarly	NULL
,	NULL
Elf-1	NULL
bound	NULL
poorly	NULL
to	NULL
a	NULL
radiolabelled	NULL
mutant	NULL
IL-2B	NULL
competitor	NULL
.	NULL

The	NULL
two	NULL
major	NULL
specific	NULL
bands	NULL
observed	NULL
with	NULL
the	NULL
recombinant	NULL
Elf-1	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
,	NULL
arrows	NULL
)	NULL
reflected	NULL
the	NULL
presence	NULL
of	NULL
several	NULL
forms	NULL
of	NULL
the	NULL
Elf-1	NULL
protein	NULL
in	NULL
the	NULL
crude	NULL
bacterial	NULL
lysate	NULL
as	NULL
assessed	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
different-sized	NULL
Elf-1	NULL
proteins	NULL
may	NULL
have	NULL
arisen	NULL
via	NULL
the	NULL
use	NULL
of	NULL
multiple	NULL
initiation	NULL
codons	NULL
or	NULL
by	NULL
proteo-lytic	NULL
breakdown	NULL
of	NULL
the	NULL
full-length	NULL
Elf-1	NULL
protein	NULL
.	NULL

In	NULL
control	NULL
experiments	NULL
,	NULL
both	NULL
in	NULL
vitro-translated	NULL
truncated	NULL
Ets-1	NULL
protein	NULL
(	NULL
containing	NULL
amino	NULL
acids	NULL
290	NULL
to	NULL
441	NULL
of	NULL
human	NULL
Ets-1	NULL
)	NULL
and	NULL
full-length	NULL
bacterially	NULL
produced	NULL
Ets-1	NULL
protein	NULL
bound	NULL
to	NULL
radiolabelled	NULL
MSV	NULL
LTR	NULL
but	NULL
failed	NULL
to	NULL
bind	NULL
to	NULL
an	NULL
NFAT-1l	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
fine	NULL
specificities	NULL
of	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
Ets-1	NULL
and	NULL
Elf-1	NULL
proteins	NULL
are	NULL
different	NULL
and	NULL
may	NULL
be	NULL
determined	NULL
by	NULL
differences	NULL
in	NULL
the	NULL
sequences	NULL
that	NULL
flank	NULL
the	NULL
Ets	NULL
core	NULL
motif	NULL
,	NULL
C/AGGAA/T	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
potential	NULL
Ets	NULL
binding	NULL
sites	NULL
can	NULL
be	NULL
identified	NULL
in	NULL
multiple	NULL
T-cell	NULL
genes	NULL
.	NULL

Thus	NULL
,	NULL
for	NULL
example	NULL
,	NULL
the	NULL
CD3R	NULL
site	NULL
in	NULL
the	NULL
HIV-2	NULL
enhancer	NULL
shared	NULL
significant	NULL
sequence	NULL
identity	NULL
with	NULL
the	NULL
IL-2	NULL
,	NULL
EBS1	NULL
,	NULL
and	NULL
EBS2	NULL
sites	NULL
.	NULL

CD3R	NULL
1050	NULL
THOMPSON	NULL
ET	NULL
AL	NULL
.	NULL

«	NULL
GQQQC	NULL
is	NULL
required	NULL
for	NULL
the	NULL
inducibility	NULL
of	NULL
HIV-2	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
cross-linking	NULL
of	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Like	NULL
EBS1	NULL
and	NULL
EBS2	NULL
,	NULL
the	NULL
CD3R	NULL
site	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
bind	NULL
Elf-1	NULL
protein	NULL
preferentially	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9A	NULL
,	NULL
the	NULL
CD3R	NULL
site	NULL
binds	NULL
in	NULL
vitro-transcribed	NULL
and	NULL
translated	NULL
Elf-1	NULL
protein	NULL
with	NULL
high	NULL
affinity	NULL
but	NULL
binds	NULL
poorly	NULL
to	NULL
the	NULL
truncated	NULL
Ets-l	NULL
protein	NULL
.	NULL

Thus	NULL
,	NULL
Elf-1	NULL
but	NULL
not	NULL
Ets-1	NULL
binds	NULL
to	NULL
multiple	NULL
sites	NULL
that	NULL
are	NULL
important	NULL
in	NULL
mediating	NULL
inducible	NULL
gene	NULL
expression	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

DISCUSSION	NULL
The	NULL
studies	NULL
described	NULL
in	NULL
this	NULL
report	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
two	NULL
predicted	NULL
Ets	NULL
binding	NULL
sites	NULL
,	NULL
EBS1	NULL
and	NULL
EBS2	NULL
,	NULL
within	NULL
the	NULL
human	NULL
IL-2	NULL
enhancer	NULL
are	NULL
required	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
previously	NULL
described	NULL
NFAT-1	NULL
and	NULL
NFIL-2B	NULL
nuclear	NULL
protein	NULL
complexes	NULL
in	NULL
vitro	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
our	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
studies	NULL
demonstrated	NULL
that	NULL
at	NULL
least	NULL
one	NULL
Ets	NULL
binding	NULL
site	NULL
is	NULL
necessary	NULL
for	NULL
IL-2	NULL
enhancer	NULL
function	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
two	NULL
distinct	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
that	NULL
the	NULL
IL-2	NULL
enhancer	NULL
can	NULL
be	NULL
divided	NULL
into	NULL
discrete	NULL
and	NULL
redundant	NULL
subdo-mains	NULL
,	NULL
one	NULL
of	NULL
which	NULL
contains	NULL
NFAT-1	NULL
(	NULL
EBS1	NULL
)	NULL
and	NULL
the	NULL
other	NULL
of	NULL
which	NULL
contains	NULL
NFIL-2B	NULL
(	NULL
EBS2	NULL
)	NULL
(	NULL
11	NULL
,	NULL
58	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
both	NULL
EBS1	NULL
and	NULL
EBS2	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
intact	NULL
IL-2	NULL
enhancer	NULL
results	NULL
in	NULL
the	NULL
complete	NULL
loss	NULL
of	NULL
transcriptional	NULL
induction	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
our	NULL
work	NULL
and	NULL
that	NULL
of	NULL
others	NULL
have	NULL
suggested	NULL
that	NULL
mutations	NULL
of	NULL
other	NULL
individual	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
IL-2	NULL
enhancer	NULL
,	NULL
including	NULL
3'NFAT	NULL
(	NULL
this	NULL
report	NULL
)	NULL
,	NULL
NF-kB	NULL
,	NULL
AP-1	NULL
,	NULL
Oct-1/2	NULL
,	NULL
and	NULL
AP-3	NULL
(	NULL
13	NULL
,	NULL
27	NULL
,	NULL
29	NULL
,	NULL
49	NULL
)	NULL
,	NULL
each	NULL
result	NULL
in	NULL
only	NULL
a	NULL
partial	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

FIG	NULL
.	NULL

8	NULL
.	NULL

Organization	NULL
and	NULL
expression	NULL
of	NULL
Elf-1	NULL
mRNA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
organization	NULL
of	NULL
the	NULL
Elf-1	NULL
cDNA	NULL
.	NULL

5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
untranslated	NULL
regions	NULL
are	NULL
shown	NULL
along	NULL
the	NULL
thin	NULL
line	NULL
;	NULL
the	NULL
ORF	NULL
is	NULL
represented	NULL
by	NULL
the	NULL
boxed	NULL
region	NULL
.	NULL

The	NULL
acidic	NULL
domain	NULL
,	NULL
Ets	NULL
domain	NULL
,	NULL
and	NULL
serine/threonine-rich	NULL
domain	NULL
are	NULL
indicated	NULL
.	NULL

Amino	NULL
acid	NULL
sequences	NULL
of	NULL
the	NULL
Ets	NULL
domains	NULL
of	NULL
Elf-1	NULL
,	NULL
E74	NULL
(	NULL
6	NULL
)	NULL
,	NULL
Ets-1	NULL
(	NULL
56	NULL
)	NULL
,	NULL
and	NULL
Ets-2	NULL
(	NULL
56	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Dashes	NULL
indicate	NULL
identity	NULL
to	NULL
the	NULL
Elf-1	NULL
sequence	NULL
.	NULL

Spaces	NULL
are	NULL
introduced	NULL
to	NULL
achieve	NULL
optimal	NULL
alignment	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
Elf-1	NULL
mRNA	NULL
.	NULL

Northern	NULL
blots	NULL
prepared	NULL
from	NULL
equal	NULL
amounts	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
from	NULL
quiescent	NULL
T	NULL
cells	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
M	NULL
)	NULL
or	NULL
activated	NULL
by	NULL
an	NULL
immobilized	NULL
anti-CD3	NULL
MAb	NULL
(	NULL
a-CD3	NULL
)	NULL
for	NULL
1	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
or	NULL
24	NULL
h	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
radiolabelled	NULL
probe	NULL
specific	NULL
for	NULL
Elf-1	NULL
(	NULL
top	NULL
)	NULL
or	NULL
HLA	NULL
class	NULL
I	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

decrease	NULL
in	NULL
activationally	NULL
induced	NULL
enhancer	NULL
function	NULL
.	NULL

Finally	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
Ets	NULL
binding	NULL
sites	NULL
appear	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
inducible	NULL
IL-2	NULL
enhancer	NULL
function	NULL
,	NULL
multimerized	NULL
EBSl	NULL
or	NULL
CD3R	NULL
Elf-1	NULL
binding	NULL
sites	NULL
do	NULL
not	NULL
function	NULL
as	NULL
inducible	NULL
transcriptional	NULL
enhancers	NULL
,	NULL
and	NULL
overexpression	NULL
of	NULL
Elf-1	NULL
does	NULL
not	NULL
by	NULL
itself	NULL
result	NULL
in	NULL
the	NULL
transactivation	NULL
of	NULL
either	NULL
the	NULL
IL-2	NULL
or	NULL
HIV-2	NULL
enhancer	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
cooperation	NULL
between	NULL
an	NULL
Ets	NULL
family	NULL
member	NULL
and	NULL
a	NULL
variety	NULL
of	NULL
inducible	NULL
DNA-binding	NULL
proteins	NULL
is	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
IL-2	NULL
and	NULL
HIV-2	NULL
enhancer	NULL
function	NULL
.	NULL

Several	NULL
types	NULL
of	NULL
data	NULL
support	NULL
the	NULL
hypothesis	NULL
that	NULL
Ets	NULL
family	NULL
members	NULL
function	NULL
to	NULL
regulate	NULL
the	NULL
IL-2	NULL
enhancer	NULL
(	NULL
and	NULL
other	NULL
enhancers	NULL
)	NULL
by	NULL
interacting	NULL
with	NULL
other	NULL
inducible	NULL
transcription	NULL
factors	NULL
bound	NULL
to	NULL
adjacent	NULL
sites	NULL
on	NULL
the	NULL
DNA	NULL
.	NULL

First	NULL
,	NULL
both	NULL
EBS1	NULL
and	NULL
EBS2	NULL
are	NULL
contained	NULL
within	NULL
DNase	NULL
I-foot-printed	NULL
sites	NULL
that	NULL
appear	NULL
to	NULL
bind	NULL
multiple	NULL
nuclear	NULL
proteins	NULL
.	NULL

Thus	NULL
,	NULL
EBS2	NULL
is	NULL
contained	NULL
within	NULL
the	NULL
previously	NULL
described	NULL
NFIL-2B	NULL
DNase	NULL
I	NULL
footprint	NULL
,	NULL
which	NULL
also	NULL
contains	NULL
an	NULL
AP-1	NULL
site	NULL
(	NULL
5	NULL
,	NULL
11	NULL
)	NULL
,	NULL
and	NULL
EBS1	NULL
is	NULL
contained	NULL
within	NULL
the	NULL
NFAT-1	NULL
footprint	NULL
,	NULL
which	NULL
also	NULL
contains	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
a	NULL
second	NULL
nuclear	NULL
protein	NULL
(	NULL
this	NULL
report	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
NFIL-2B	NULL
footprint	NULL
could	NULL
be	NULL
the	NULL
result	NULL
of	NULL
the	NULL
inducible	NULL
binding	NULL
of	NULL
a	NULL
nuclear	NULL
protein	NULL
complex	NULL
which	NULL
contains	NULL
AP-1	NULL
as	NULL
well	NULL
as	NULL
an	NULL
Ets	NULL
family	NULL
member	NULL
.	NULL

Wasylyk	NULL
and	NULL
colleagues	NULL
(	NULL
55	NULL
)	NULL
have	NULL
shown	NULL
recently	NULL
that	NULL
Ets-1	NULL
and	NULL
AP-1	NULL
(	NULL
Fos/Jun	NULL
)	NULL
cooperatively	NULL
interact	NULL
in	NULL
such	NULL
a	NULL
complex	NULL
by	NULL
binding	NULL
to	NULL
a	NULL
14-bp	NULL
region	NULL
in	NULL
the	NULL
polyomavirus	NULL
enhancer	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
Ets-1	NULL
also	NULL
binds	NULL
to	NULL
the	NULL
TCR	NULL
a	NULL
enhancer	NULL
in	NULL
concert	NULL
with	NULL
a	NULL
second	NULL
non-Ets	NULL
protein	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
as	NULL
is	NULL
the	NULL
case	NULL
for	NULL
EBS1	NULL
and	NULL
EBS2	NULL
,	NULL
the	NULL
Ets	NULL
binding	NULL
sites	NULL
in	NULL
both	NULL
the	NULL
TCR	NULL
a	NULL
and	NULL
polyomavirus	NULL
enhancers	NULL
are	NULL
required	NULL
for	NULL
enhancer	NULL
activity	NULL
,	NULL
yet	NULL
these	NULL
sites	NULL
by	NULL
themselves	NULL
do	NULL
not	NULL
display	NULL
enhancer	NULL
function	NULL
,	NULL
nor	NULL
does	NULL
overexpression	NULL
of	NULL
Ets-1	NULL
alone	NULL
activate	NULL
these	NULL
enhancers	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
A.	NULL
Reticulocyte	NULL
Lysate	NULL
Ets-1	NULL
Elf-1	NULL
Ets-1	NULL
Elf-1	NULL
Ets-1	NULL
Elf-1	NULL
Elf-1	NULL
-	NULL
»	NULL
A	NULL
seo	NULL
bal	NULL
aes	NULL
Ets-1	NULL
-	NULL
»	NULL
#	NULL
Ta2	NULL
NFAT	NULL
HIV-2	NULL
LTR	NULL
B.	NULL
Recombinant	NULL
EH-1l	NULL
:	NULL
%	NULL
i	NULL
%	NULL
Ets	NULL
BINDING	NULL
SITES	NULL
IN	NULL
THE	NULL
IL-2	NULL
ENHANCER	NULL
1051	NULL
B	NULL
B	NULL
G	NULL
C	NULL
C	NULL
C	NULL
C	NULL
S	NULL
r	NULL
ar	NULL
E	NULL
5	NULL
r-	NULL
x	NULL
T	NULL
=	NULL
‘	NULL
g	NULL
’	NULL
hos	NULL
‘	NULL
g	NULL
’	NULL
ral	NULL
Protein	NULL
:	NULL
8	NULL
&	NULL
8	NULL
&	NULL
8	NULL
&	NULL
8	NULL
&	NULL
8§	NULL
8	NULL
&	NULL
8	NULL
&	NULL
NFAT	NULL
-	NULL
mNFAT	NULL
IL-2B	NULL
-	NULL
miL-28	NULL
MSV	NULL
LTR	NULL
-	NULL
To2	NULL
To3	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

EMSA	NULL
analysis	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
specificities	NULL
of	NULL
Ets-1	NULL
and	NULL
Elf-1	NULL
proteins	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSAs	NULL
using	NULL
in	NULL
vitro-transcribed	NULL
and	NULL
-translated	NULL
Ets-1	NULL
and	NULL
Elf-1	NULL
proteins	NULL
.	NULL

Individual	NULL
radiolabelled	NULL
probes	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Control	NULL
lysates	NULL
(	NULL
-	NULL
)	NULL
were	NULL
translated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
exogenous	NULL
RNA	NULL
.	NULL

Bands	NULL
of	NULL
altered	NULL
mobility	NULL
corresponding	NULL
to	NULL
binding	NULL
of	NULL
the	NULL
in	NULL
vitro-translated	NULL
Ets-1	NULL
and	NULL
Elf-1	NULL
proteins	NULL
are	NULL
shown	NULL
with	NULL
arrows	NULL
and	NULL
labelled	NULL
at	NULL
the	NULL
left	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSAs	NULL
using	NULL
bacterially	NULL
produced	NULL
recombinant	NULL
Elf-1	NULL
protein	NULL
.	NULL

Individual	NULL
radiolabelled	NULL
probes	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

Control	NULL
binding	NULL
reaction	NULL
mixtures	NULL
contained	NULL
bacterial	NULL
protein	NULL
prepared	NULL
from	NULL
cells	NULL
containing	NULL
the	NULL
pET-3b	NULL
expression	NULL
vector	NULL
without	NULL
the	NULL
Elf-1	NULL
cDNA	NULL
.	NULL

Bands	NULL
of	NULL
altered	NULL
mobility	NULL
corresponding	NULL
to	NULL
binding	NULL
of	NULL
the	NULL
recombinant	NULL
Elf-1	NULL
protein	NULL
are	NULL
shown	NULL
with	NULL
arrows	NULL
and	NULL
labelled	NULL
.	NULL

EBS1	NULL
also	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
component	NULL
of	NULL
a	NULL
larger	NULL
,	NULL
more	NULL
complex	NULL
nuclear	NULL
binding	NULL
site	NULL
referred	NULL
to	NULL
as	NULL
NFAT-1	NULL
(	NULL
47	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
containing	NULL
EBS1	NULL
,	NULL
NFAT-1	NULL
appears	NULL
to	NULL
contain	NULL
the	NULL
recognition	NULL
sequence	NULL
for	NULL
a	NULL
second	NULL
nuclear	NULL
protein	NULL
that	NULL
we	NULL
have	NULL
called	NULL
3'NFAT	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
multimerized	NULL
NFAT-1	NULL
oligonucleotides	NULL
to	NULL
confer	NULL
T-cell-activating	NULL
properties	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
requires	NULL
both	NULL
a	NULL
functional	NULL
EBS1	NULL
site	NULL
and	NULL
a	NULL
functional	NULL
3'NFAT-1	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
again	NULL
consistent	NULL
with	NULL
the	NULL
idea	NULL
that	NULL
Ets	NULL
proteins	NULL
function	NULL
as	NULL
transcriptional	NULL
cofactors	NULL
.	NULL

It	NULL
is	NULL
also	NULL
important	NULL
to	NULL
emphasize	NULL
that	NULL
the	NULL
3'NFAT	NULL
site	NULL
is	NULL
not	NULL
the	NULL
only	NULL
site	NULL
that	NULL
can	NULL
cooperate	NULL
with	NULL
EBS1	NULL
and/or	NULL
EBS2	NULL
to	NULL
activate	NULL
the	NULL
IL-2	NULL
enhancer	NULL
.	NULL

The	NULL
IL-2	NULL
enhancer	NULL
containing	NULL
a	NULL
mutated	NULL
3'NFAT	NULL
site	NULL
was	NULL
still	NULL
induced	NULL
by	NULL
27-fold	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
enhancer	NULL
truncations	NULL
lacking	NULL
the	NULL
entire	NULL
NFAT-1	NULL
site	NULL
but	NULL
still	NULL
containing	NULL
the	NULL
API	NULL
,	NULL
NF-kB	NULL
,	NULL
AP-3	NULL
,	NULL
and	NULL
EBS2	NULL
sites	NULL
retain	NULL
a	NULL
significant	NULL
degree	NULL
of	NULL
inducibility	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
IL-2	NULL
enhancer	NULL
contains	NULL
functional	NULL
binding	NULL
sites	NULL
for	NULL
AP-1	NULL
,	NULL
AP-3	NULL
,	NULL
OCT-1/2	NULL
,	NULL
and	NULL
NF-KB	NULL
(	NULL
5	NULL
,	NULL
13	NULL
,	NULL
27	NULL
,	NULL
29	NULL
,	NULL
36	NULL
,	NULL
48	NULL
)	NULL
,	NULL
Ets	NULL
proteins	NULL
could	NULL
potentially	NULL
interact	NULL
with	NULL
a	NULL
number	NULL
of	NULL
different	NULL
inducible	NULL
transcription	NULL
factors	NULL
to	NULL
regulate	NULL
IL-2	NULL
transcription	NULL
.	NULL

Although	NULL
the	NULL
studies	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
have	NULL
demonstrated	NULL
that	NULL
Ets	NULL
binding	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
HIV-2	NULL
enhancers	NULL
,	NULL
the	NULL
identities	NULL
of	NULL
these	NULL
Ets	NULL
proteins	NULL
remain	NULL
unresolved	NULL
.	NULL

None	NULL
of	NULL
the	NULL
proteins	NULL
that	NULL
can	NULL
be	NULL
UV	NULL
cross-linked	NULL
to	NULL
a	NULL
BrdU-substituted	NULL
NFAT-1	NULL
probe	NULL
correspond	NULL
in	NULL
size	NULL
to	NULL
Ets-1	NULL
(	NULL
51/48	NULL
kDa	NULL
)	NULL
or	NULL
Ets-2	NULL
(	NULL
56	NULL
kDa	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
fail	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
IL-2	NULL
enhancer	NULL
and	NULL
are	NULL
therefore	NULL
not	NULL
candidates	NULL
for	NULL
the	NULL
IL-2	NULL
regulatory	NULL
proteins	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
Elf-1	NULL
gene	NULL
reported	NULL
here	NULL
does	NULL
bind	NULL
to	NULL
both	NULL
EBS1	NULL
and	NULL
EBS2	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
and	NULL
to	NULL
the	NULL
CD3R	NULL
site	NULL
in	NULL
the	NULL
HIV-2	NULL
enhancer	NULL
and	NULL
could	NULL
,	NULL
therefore	NULL
,	NULL
play	NULL
a	NULL
role	NULL
in	NULL
regulating	NULL
both	NULL
IL-2	NULL
and	NULL
HIV-2	NULL
transcription	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
predicted	NULL
size	NULL
of	NULL
Elf-1	NULL
(	NULL
68	NULL
kDa	NULL
)	NULL
corresponds	NULL
closely	NULL
to	NULL
the	NULL
size	NULL
of	NULL
one	NULL
of	NULL
the	NULL
proteins	NULL
that	NULL
can	NULL
be	NULL
cross-linked	NULL
to	NULL
a	NULL
BrdU-substituted	NULL
NFAT-1	NULL
probe	NULL
.	NULL

Previous	NULL
studies	NULL
using	NULL
T-cell	NULL
tumor	NULL
cells	NULL
have	NULL
dem	NULL
onstrated	NULL
that	NULL
the	NULL
NFAT-1	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
T-cell	NULL
specific	NULL
and	NULL
is	NULL
observed	NULL
only	NULL
following	NULL
T-cell	NULL
activation	NULL
(	NULL
11	NULL
,	NULL
47	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NFAT-1	NULL
binding	NULL
activity	NULL
is	NULL
blocked	NULL
by	NULL
inhibitors	NULL
of	NULL
protein	NULL
synthesis	NULL
such	NULL
as	NULL
cycloheximide	NULL
(	NULL
47	NULL
)	NULL
.	NULL

We	NULL
have	NULL
confirmed	NULL
these	NULL
results	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Northern	NULL
blot	NULL
analyses	NULL
have	NULL
shown	NULL
that	NULL
Elf-1	NULL
mRNA	NULL
(	NULL
3.8	NULL
kb	NULL
)	NULL
is	NULL
expressed	NULL
in	NULL
mouse	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
kidney	NULL
.	NULL

In	NULL
addition	NULL
Elf-1	NULL
mRNA	NULL
is	NULL
expressed	NULL
both	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
resting	NULL
as	NULL
well	NULL
as	NULL
activated	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
levels	NULL
of	NULL
NFAT-1	NULL
binding	NULL
activity	NULL
do	NULL
not	NULL
correlate	NULL
with	NULL
Elf-1	NULL
mRNA	NULL
levels	NULL
.	NULL

However	NULL
,	NULL
it	NULL
remains	NULL
possible	NULL
that	NULL
EIf-1	NULL
DNA	NULL
binding	NULL
activity	NULL
might	NULL
be	NULL
regulated	NULL
in	NULL
vivo	NULL
at	NULL
the	NULL
posttranscriptional	NULL
or	NULL
posttranslational	NULL
level	NULL
.	NULL

Alternatively	NULL
,	NULL
because	NULL
EBS1	NULL
and	NULL
3'NFAT	NULL
both	NULL
appear	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
NFAT-1	NULL
complex	NULL
to	NULL
DNA	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
3'NFAT	NULL
site	NULL
are	NULL
T-cell	NULL
specific	NULL
and	NULL
activationally	NULL
induced	NULL
.	NULL

In	NULL
this	NULL
model	NULL
,	NULL
the	NULL
inducibility	NULL
and	NULL
T-cell	NULL
specificity	NULL
of	NULL
the	NULL
full	NULL
IL-2	NULL
enhancer	NULL
would	NULL
be	NULL
regulated	NULL
by	NULL
3'NFAT	NULL
,	NULL
AP-1	NULL
,	NULL
NF-kB	NULL
,	NULL
and/or	NULL
AP-3	NULL
,	NULL
whereas	NULL
Elf-1	NULL
would	NULL
be	NULL
an	NULL
essential	NULL
cofactor	NULL
which	NULL
functions	NULL
to	NULL
integrate	NULL
the	NULL
combined	NULL
effects	NULL
of	NULL
these	NULL
other	NULL
inducible	NULL
transcription	NULL
factors	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
it	NULL
is	NULL
an	NULL
Elf-l-related	NULL
protein	NULL
,	NULL
and	NULL
not	NULL
Elf-1	NULL
itself	NULL
,	NULL
that	NULL
regulates	NULL
IL-2	NULL
and	NULL
HIV-2	NULL
enhancer	NULL
activities	NULL
in	NULL
vivo	NULL
.	NULL

It	NULL
may	NULL
be	NULL
quite	NULL
difficult	NULL
to	NULL
resolve	NULL
these	NULL
possibilities	NULL
because	NULL
it	NULL
is	NULL
now	NULL
clear	NULL
that	NULL
many	NULL
Ets	NULL
proteins	NULL
are	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
that	NULL
many	NULL
anti-Ets	NULL
antibodies	NULL
cross-react	NULL
with	NULL
multiple	NULL
Ets	NULL
proteins	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
unequivocal	NULL
identification	NULL
of	NULL
the	NULL
Ets	NULL
pro-tein	NULL
(	NULL
s	NULL
)	NULL
that	NULL
regulates	NULL
the	NULL
IL-2	NULL
and	NULL
HIV-2	NULL
enhancers	NULL
in	NULL
vivo	NULL
will	NULL
probably	NULL
require	NULL
the	NULL
characterization	NULL
of	NULL
additional	NULL
Ets	NULL
family	NULL
members	NULL
expressed	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
generation	NULL
of	NULL
antibody	NULL
reagents	NULL
that	NULL
are	NULL
specific	NULL
for	NULL
each	NULL
of	NULL
these	NULL
related	NULL
Ets	NULL
family	NULL
members	NULL
,	NULL
and	NULL
antisense	NULL
and	NULL
gene	NULL
knockout	NULL
experiments	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
and	NULL
animals	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
it	NULL
now	NULL
appears	NULL
that	NULL
multiple	NULL
Ets	NULL
family	NULL
members	NULL
are	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
that	NULL
these	NULL
proteins	NULL
display	NULL
distinct	NULL
patterns	NULL
of	NULL
expression	NULL
and	NULL
DNA	NULL
binding	NULL
specificities	NULL
.	NULL

Such	NULL
heterogeneity	NULL
may	NULL
help	NULL
explain	NULL
how	NULL
Ets	NULL
gene	NULL
products	NULL
1052	NULL
THOMPSON	NULL
ET	NULL
AL	NULL
.	NULL

contribute	NULL
to	NULL
the	NULL
regulated	NULL
expression	NULL
of	NULL
different	NULL
sets	NULL
of	NULL
genes	NULL
during	NULL
both	NULL
T-cell	NULL
development	NULL
and	NULL
activation	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Chao-lan	NULL
Yu	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
grant	NULL
AI-29673	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
to	NULL
J.	NULL
M.L	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

REFERENCES	NULL
.	NULL

Altman	NULL
,	NULL
A.	NULL
,	NULL
K.	NULL
M.	NULL
Coggeshall	NULL
,	NULL
and	NULL
T.	NULL
Mustelin	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
events	NULL
mediating	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

48:227-360.	NULL
.	NULL

Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
K.	NULL
L.	NULL
Komschlies	NULL
,	NULL
S.	NULL
Fujiwara	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
B.	NULL
J.	NULL
Mathieson	NULL
,	NULL
T.	NULL
A.	NULL
Gregorio	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
J.	NULL
W.	NULL
Kasik	NULL
,	NULL
K.	NULL
Ozato	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1989	NULL
.	NULL

Expression	NULL
of	NULL
ets	NULL
genes	NULL
in	NULL
mouse	NULL
thymocyte	NULL
subsets	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:672-678.	NULL
.	NULL

Bielinska	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
A.	NULL
Shivdasani	NULL
,	NULL
L.	NULL
Zhang	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
gene	NULL
expression	NULL
with	NULL
double-stranded	NULL
phospho-rothioate	NULL
oligonucleotides	NULL
.	NULL

Science	NULL
250:997-1000.	NULL
.	NULL

Bosselut	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
F.	NULL
Duvall	NULL
,	NULL
A.	NULL
Gegonne	NULL
,	NULL
M.	NULL
Bailly	NULL
,	NULL
A.	NULL
Hemar	NULL
,	NULL
J.	NULL
Brady	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
product	NULL
of	NULL
the	NULL
c-ets-1	NULL
proto-oncogene	NULL
and	NULL
the	NULL
related	NULL
Ets2	NULL
protein	NULL
act	NULL
as	NULL
transcriptional	NULL
activators	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
HTLV-1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:3137-3144.	NULL
.	NULL

Brunvand	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
A.	NULL
Schmidt	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1988	NULL
.	NULL

Nuclear	NULL
factors	NULL
interacting	NULL
with	NULL
the	NULL
mitogen-responsive	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263:18904-18910.	NULL
.	NULL

Burtis	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
C.	NULL
S.	NULL
Thummel	NULL
,	NULL
C.	NULL
W.	NULL
Jones	NULL
,	NULL
F.	NULL
D.	NULL
Karim	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Hogness	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
Drosophila	NULL
74EF	NULL
early	NULL
puff	NULL
contains	NULL
E74	NULL
,	NULL
a	NULL
complex	NULL
ecdysone-inducible	NULL
gene	NULL
that	NULL
encodes	NULL
two	NULL
ets-related	NULL
proteins	NULL
.	NULL

Cell	NULL
61:85-99.	NULL
.	NULL

Cantrell	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Smith	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
interleukin-2	NULL
T-cell	NULL
system	NULL
:	NULL
a	NULL
new	NULL
cell	NULL
growth	NULL
model	NULL
.	NULL

Science	NULL
224:1312-1316.	NULL
.	NULL

Clevers	NULL
,	NULL
H.	NULL
,	NULL
N.	NULL
Lonberg	NULL
,	NULL
S.	NULL
Dunlap	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
and	NULL
C.	NULL
Terhorst	NULL
.	NULL

1989	NULL
.	NULL

An	NULL
enhancer	NULL
located	NULL
in	NULL
a	NULL
CpG-island	NULL
3	NULL
'	NULL
to	NULL
the	NULL
TCR/CD3-s	NULL
gene	NULL
confers	NULL
T	NULL
lymphocyte-specificity	NULL
to	NULL
its	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:2527-2535.	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
1989	NULL
.	NULL

Contingent	NULL
genetic	NULL
regulatory	NULL
events	NULL
in	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Science	NULL
243:355-361	NULL
.	NULL

Davis	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Bjorkman	NULL
.	NULL

1988	NULL
.	NULL

T-cell	NULL
antigen	NULL
receptor	NULL
genes	NULL
and	NULL
T-cell	NULL
recognition	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
334:395-402	NULL
.	NULL

Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
J.-P.	NULL
Shaw	NULL
,	NULL
M.	NULL
R.	NULL
Bush	NULL
,	NULL
R.	NULL
E.	NULL
Replogle	NULL
,	NULL
R.	NULL
Belagaje	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
antigen	NULL
receptor	NULL
response	NULL
elements	NULL
within	NULL
the	NULL
interleukin-2	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1715-1724	NULL
.	NULL

Efrat	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Pilo	NULL
,	NULL
and	NULL
R.	NULL
Kaempfer	NULL
.	NULL

1982	NULL
.	NULL

Kinetics	NULL
of	NULL
induction	NULL
and	NULL
molecular	NULL
size	NULL
of	NULL
mRNAs	NULL
encoding	NULL
human	NULL
interleukin-2	NULL
and	NULL
gamma-interferon	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
297:236-239	NULL
.	NULL

Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
C.	NULL
L.	NULL
Verweij	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
K.	NULL
M.	NULL
Higgins	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1989	NULL
.	NULL

Cyclosporin	NULL
A	NULL
specifically	NULL
inhibits	NULL
function	NULL
of	NULL
nuclear	NULL
proteins	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
246:1617-1620	NULL
.	NULL

Fiering	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
P.	NULL
Northrop	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
P.	NULL
S.	NULL
Mattila	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
.	NULL

1990	NULL
.	NULL

Single	NULL
cell	NULL
assay	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
reveals	NULL
a	NULL
threshold	NULL
in	NULL
transcription	NULL
activated	NULL
by	NULL
signals	NULL
emanating	NULL
from	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1823-1834	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Shibuya	NULL
,	NULL
T.	NULL
Ohashi	NULL
,	NULL
K.	NULL
Yamanishi	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1986	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
interleukin-2	NULL
gene	NULL
:	NULL
functional	NULL
DNA	NULL
sequences	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
for	NULL
the	NULL
gene	NULL
expression	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
46:401-407	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
C.	NULL
Takaoka	NULL
,	NULL
H.	NULL
Matsui	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1983	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
human	NULL
interleukin	NULL
2	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80:7437-7441	NULL
.	NULL

Fujiwara	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Koizumi	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
N.	NULL
K.	NULL
Bhat	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1990	NULL
.	NULL

Phosphorylation	NULL
of	NULL
the	NULL
Ets-2	NULL
protein	NULL
:	NULL
regulation	NULL
by	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor-CD3	NULL
complex	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:1249-1253	NULL
.	NULL

Fuse	NULL
,	NULL
A.	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
H.	NULL
Yasumitsu	NULL
,	NULL
N.	NULL
Kashima	NULL
,	NULL
K.	NULL
Hasegawa	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1984	NULL
.	NULL

Organization	NULL
and	NULL
structure	NULL
of	NULL
the	NULL
mouse	NULL
interleukin-2	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12:9323-9331	NULL
.	NULL

Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
P.	NULL
van	NULL
den	NULL
Elsen	NULL
,	NULL
E.	NULL
Bier	NULL
,	NULL
A.	NULL
Maxam	NULL
,	NULL
and	NULL
C.	NULL
Terhorst	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
T	NULL
cell-specific	NULL
enhancer	NULL
is	NULL
located	NULL
in	NULL
a	NULL
DNase	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Broc	NULL
.	NULL

I-hypersensitive	NULL
area	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
CD3-8	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:2401-2407	NULL
.	NULL

Gottschalk	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
B	NULL
gene	NULL
transcriptional	NULL
enhancer	NULL
:	NULL
common	NULL
nuclear	NULL
proteins	NULL
interact	NULL
with	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
a	NULL
and	NULL
B	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:5486-5495	NULL
.	NULL

Gunther	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Nye	NULL
,	NULL
R.	NULL
S.	NULL
Bryner	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1990	NULL
.	NULL

Sequence-specific	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
proto-oncoprotein	NULL
ets-1	NULL
defines	NULL
a	NULL
transcriptional	NULL
activator	NULL
sequence	NULL
within	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
the	NULL
Moloney	NULL
murine	NULL
sarcoma	NULL
virus	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:667-679	NULL
.	NULL

Guyader	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Emerman	NULL
,	NULL
P.	NULL
Sonigo	NULL
,	NULL
F.	NULL
Clavel	NULL
,	NULL
L.	NULL
Montagnier	NULL
,	NULL
and	NULL
M.	NULL
Alizon	NULL
.	NULL

1987	NULL
.	NULL

Genome	NULL
organization	NULL
and	NULL
transactivation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:662-669	NULL
.	NULL

Ho	NULL
,	NULL
I.-C.	NULL
,	NULL
N.	NULL
K.	NULL
Bhat	NULL
,	NULL
L.	NULL
R.	NULL
Gottschalk	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
T.	NULL
S.	NULL
Papas	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1990	NULL
.	NULL

Sequence-specific	NULL
binding	NULL
of	NULL
human	NULL
ets-1	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
a	NULL
gene	NULL
enhancer	NULL
.	NULL

Science	NULL
250:814-818	NULL
.	NULL

Ho	NULL
,	NULL
I.-C.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
a	NULL
gene	NULL
enhancer	NULL
:	NULL
multiple	NULL
ubiquitous	NULL
and	NULL
T-cell-specific	NULL
nuclear	NULL
proteins	NULL
interact	NULL
with	NULL
four	NULL
hypomethylated	NULL
enhancer	NULL
elements	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:4720-4727	NULL
.	NULL

Ho	NULL
,	NULL
I.-C.	NULL
,	NULL
L.-H.	NULL
Yang	NULL
,	NULL
G.	NULL
Morle	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
T-cell-specific	NULL
transcription	NULL
enhancer	NULL
element	NULL
3	NULL
'	NULL
of	NULL
Ca	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
a	NULL
locus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:6714-6718	NULL
.	NULL

Holbrook	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
M.	NULL
Lieber	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1984	NULL
.	NULL

DNA	NULL
sequence	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
interleukin	NULL
2	NULL
gene	NULL
:	NULL
homologies	NULL
with	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12:5005-5013	NULL
.	NULL

Hoyos	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
M.	NULL
Siekevitz	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Kappa	NULL
B-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
:	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
human	NULL
interleukin-2	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
244:457-460	NULL
.	NULL

June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
M.	NULL
M.	NULL
Gillespie	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1987	NULL
.	NULL

T-cell	NULL
proliferation	NULL
involving	NULL
the	NULL
CD28	NULL
pathway	NULL
is	NULL
associated	NULL
with	NULL
cyclosporine-resistant	NULL
interleukin	NULL
2	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:4472-4481	NULL
.	NULL

Kamps	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
L.	NULL
Corcoran	NULL
,	NULL
J.	NULL
H.	NULL
LeBowitz	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
gene	NULL
contains	NULL
two	NULL
octamer-binding	NULL
sites	NULL
and	NULL
is	NULL
partially	NULL
activated	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
Oct-2	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:5464-5472	NULL
.	NULL

Karim	NULL
,	NULL
F.	NULL
D.	NULL
,	NULL
L.	NULL
D.	NULL
Urness	NULL
,	NULL
C.	NULL
S.	NULL
Thummel	NULL
,	NULL
M.	NULL
J.	NULL
Klemsz	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
C.	NULL
Van	NULL
Beveren	NULL
,	NULL
R.	NULL
A.	NULL
Maki	NULL
,	NULL
C.	NULL
V.	NULL
Gunther	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Nye	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
ETS-domain	NULL
:	NULL
a	NULL
new	NULL
DNA-binding	NULL
motif	NULL
that	NULL
recognizes	NULL
a	NULL
purine-rich	NULL
core	NULL
DNA	NULL
sequence	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1451-1453	NULL
.	NULL

Karpinski	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
L.-H.	NULL
Yang	NULL
,	NULL
P.	NULL
Cacheris	NULL
,	NULL
G.	NULL
D.	NULL
Morle	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
first	NULL
intron	NULL
of	NULL
the	NULL
4F2	NULL
heavy-chain	NULL
gene	NULL
contains	NULL
a	NULL
transcriptional	NULL
enhancer	NULL
element	NULL
that	NULL
binds	NULL
multiple	NULL
nuclear	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:2588-2597	NULL
.	NULL

Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
C.	NULL
Van	NULL
Beveren	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Maki	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
macrophage	NULL
and	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
PU.1	NULL
is	NULL
related	NULL
to	NULL
the	NULL
ers	NULL
oncogene	NULL
.	NULL

Cell	NULL
61:113-124	NULL
.	NULL

Kozak	NULL
,	NULL
M.	NULL
1984	NULL
.	NULL

Compilation	NULL
and	NULL
analysis	NULL
of	NULL
sequences	NULL
upstream	NULL
from	NULL
the	NULL
translational	NULL
start	NULL
site	NULL
in	NULL
eukaryotic	NULL
mRNAs	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

12:857-872	NULL
.	NULL

Kronke	NULL
,	NULL
M.	NULL
,	NULL
W.	NULL
J.	NULL
Leonard	NULL
,	NULL
J.	NULL
M.	NULL
Depper	NULL
,	NULL
S.	NULL
K.	NULL
Arya	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
T.	NULL
A.	NULL
Waldmann	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1984	NULL
.	NULL

Cyclosporin	NULL
A	NULL
inhibits	NULL
T-cell	NULL
growth	NULL
factor	NULL
gene	NULL
expression	NULL
at	NULL
the	NULL
level	NULL
of	NULL
mRNA	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
$	NULL
1:5214-5218	NULL
.	NULL

Lake	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
D.	NULL
Wotton	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Owen	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
3	NULL
'	NULL
transcriptional	NULL
enhancer	NULL
regulates	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
CD2	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:3129-3136	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
A.	NULL
Kuang	NULL
,	NULL
A.	NULL
Gifford	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
protein	NULL
purification	NULL
from	NULL
bovine	NULL
spleen	NULL
:	NULL
nucleotide	NULL
stimulation	NULL
and	NULL
binding	NULL
site	NULL
specificity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:8825-8829	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
transactivator	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

47.	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
333:776-778	NULL
.	NULL

Markovitz	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
M.	NULL
Hannibal	NULL
,	NULL
V.	NULL
L.	NULL
Perez	NULL
,	NULL
C.	NULL
Gauntt	NULL
,	NULL
T.	NULL
W.	NULL
Folks	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1990	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
viruses	NULL
(	NULL
HIV	NULL
's	NULL
)	NULL
:	NULL
a	NULL
specific	NULL
regulatory	NULL
element	NULL
in	NULL
HIV-2	NULL
responds	NULL
to	NULL
stimulation	NULL
of	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:9098-9102	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1989	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Science	NULL
245:371-378.	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Otsuka	NULL
,	NULL
T.	NULL
Yokota	NULL
,	NULL
F.	NULL
Lee	NULL
,	NULL
and	NULL
K.	NULL
Arai	NULL
.	NULL

1985	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
chromosomal	NULL
gene	NULL
for	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
:	NULL
comparison	NULL
of	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
genes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

4:2561-2568	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Yokota	NULL
,	NULL
F.	NULL
Lee	NULL
,	NULL
and	NULL
K.	NULL
Arai	NULL
.	NULL

1985	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
chromosomal	NULL
gene	NULL
for	NULL
murine	NULL
interleukin-3	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:316-320	NULL
.	NULL

Pognonec	NULL
,	NULL
P.	NULL
,	NULL
K.	NULL
E.	NULL
Boulukos	NULL
,	NULL
J.	NULL
C.	NULL
Gesquiere	NULL
,	NULL
D.	NULL
Stehelin	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1988	NULL
.	NULL

Mitogenic	NULL
stimulation	NULL
of	NULL
thymocytes	NULL
results	NULL
in	NULL
the	NULL
calcium-dependent	NULL
phosphorylation	NULL
of	NULL
c-ets-1	NULL
proteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:977-983	NULL
.	NULL

Randak	NULL
,	NULL
C.	NULL
,	NULL
T.	NULL
Brabletz	NULL
,	NULL
M.	NULL
Hergenrother	NULL
,	NULL
I.	NULL
Sobotta	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1990	NULL
.	NULL

Cyclosporin	NULL
A	NULL
suppresses	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
gene	NULL
by	NULL
inhibiting	NULL
the	NULL
binding	NULL
of	NULL
lymphocyte-specific	NULL
factors	NULL
to	NULL
the	NULL
IL-2	NULL
enhancer	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:2529-2536.	NULL
.	NULL

Redondo	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
S.	NULL
Hata	NULL
,	NULL
C.	NULL
Brocklehurst	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Krangel	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
T	NULL
cell-specific	NULL
transcriptional	NULL
enhancer	NULL
within	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
8	NULL
locus	NULL
.	NULL

Science	NULL
247:1225-1229	NULL
.	NULL

Rosenstreich	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
S.	NULL
B.	NULL
Mizel	NULL
.	NULL

1979	NULL
.	NULL

Signal	NULL
requirements	NULL
for	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

I	NULL
.	NULL

Replacement	NULL
of	NULL
macrophage	NULL
function	NULL
with	NULL
phorbol	NULL
myristic	NULL
acetate	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

123:1749-1754.	NULL
.	NULL

Serfling	NULL
,	NULL
E.	NULL
,	NULL
R.	NULL
Barthelmas	NULL
,	NULL
I.	NULL
Pfeuffer	NULL
,	NULL
B.	NULL
Schenk	NULL
,	NULL
S.	NULL
Zarius	NULL
,	NULL
R.	NULL
Swoboda	NULL
,	NULL
F.	NULL
Mercurio	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1989	NULL
.	NULL

Ubiquitous	NULL
and	NULL
lymphocyte-specific	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
mouse	NULL
interleukin	NULL
2	NULL
gene	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:465-473	NULL
.	NULL

Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
P.	NULL
J.	NULL
Utz	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
J.	NULL
J.	NULL
Toole	NULL
,	NULL
E.	NULL
A.	NULL
Emmel	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
241:202-205.	NULL
.	NULL

Shibuya	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1989	NULL
.	NULL

Identification	NULL
of	NULL
multiple	NULL
cis-elements	NULL
and	NULL
trans-acting	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
induced	NULL
expression	NULL
of	NULL
human	NULL
IL-2	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:9173-9183	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

Ets	NULL
BINDING	NULL
SITES	NULL
IN	NULL
THE	NULL
IL-2	NULL
ENHANCER	NULL
1053	NULL
Shibuya	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Yoneyama	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1989	NULL
.	NULL

Involvement	NULL
of	NULL
a	NULL
common	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
regulated	NULL
expression	NULL
of	NULL
IL-2	NULL
and	NULL
IL-2	NULL
receptor	NULL
genes	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

1:43-49	NULL
.	NULL

Sicbenlist	NULL
,	NULL
U.	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
C.	NULL
A.	NULL
Norris	NULL
,	NULL
M.	NULL
Kamoun	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Kant	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1986	NULL
.	NULL

Promoter	NULL
region	NULL
of	NULL
interleukin-2	NULL
gene	NULL
undergoes	NULL
chromatin	NULL
structure	NULL
changes	NULL
and	NULL
confers	NULL
inducibility	NULL
on	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
during	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:3042-3049	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

1980	NULL
.	NULL

T-cell	NULL
growth	NULL
factor	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

51:337-357	NULL
.	NULL

Studier	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
A.	NULL
H.	NULL
Rosenberg	NULL
,	NULL
J.	NULL
J.	NULL
Dunn	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Dubendorff	NULL
.	NULL

1990	NULL
.	NULL

Use	NULL
of	NULL
T7	NULL
RNA	NULL
polymerase	NULL
to	NULL
direct	NULL
expression	NULL
of	NULL
cloned	NULL
genes	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

185:60-89	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Matsui	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
C.	NULL
Takaoka	NULL
,	NULL
N.	NULL
Kashima	NULL
,	NULL
R.	NULL
Yoshimoto	NULL
,	NULL
and	NULL
J.	NULL
Hamuro	NULL
.	NULL

1983	NULL
.	NULL

Structure	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
cloned	NULL
cDNA	NULL
for	NULL
human	NULL
interleukin	NULL
2	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
302	NULL
:	NULL
305-309	NULL
.	NULL

Urness	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
and	NULL
C.	NULL
S.	NULL
Thummel	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
interactions	NULL
within	NULL
the	NULL
ecdysone	NULL
regulatory	NULL
hierarchy	NULL
:	NULL
DNA	NULL
binding	NULL
properties	NULL
of	NULL
the	NULL
Drosophila	NULL
ecdysone-inducible	NULL
E74A	NULL
protein	NULL
.	NULL

Cell	NULL
63:47-61	NULL
.	NULL

Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
C.	NULL
Wasylyk	NULL
,	NULL
P.	NULL
Flores	NULL
,	NULL
A.	NULL
Begue	NULL
,	NULL
D.	NULL
Leprince	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
c-ets	NULL
proto-oncogenes	NULL
encode	NULL
transcription	NULL
factors	NULL
that	NULL
cooperate	NULL
with	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
346:191-193	NULL
.	NULL

Watson	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
M.	NULL
J.	NULL
McWilliams	NULL
,	NULL
P.	NULL
Lapis	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Lautenberger	NULL
,	NULL
C.	NULL
W.	NULL
Schweinfest	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1988	NULL
.	NULL

Mammalian	NULL
ets-/	NULL
and	NULL
ets-2	NULL
genes	NULL
encode	NULL
highly	NULL
conserved	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:7862-7866	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
L.	NULL
Wiskocil	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Stobo	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
role	NULL
of	NULL
T3	NULL
surface	NULL
molecules	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
:	NULL
a	NULL
two-stimulus	NULL
requirement	NULL
for	NULL
IL-2	NULL
production	NULL
reflects	NULL
events	NULL
occurring	NULL
at	NULL
a	NULL
pre-translational	NULL
level	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

133:123-128	NULL
.	NULL

Williams	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
L.	NULL
Eisenberg	NULL
,	NULL
J.	NULL
E.	NULL
Burlein	NULL
,	NULL
C.	NULL
A.	NULL
Norris	NULL
,	NULL
S.	NULL
Pancer	NULL
,	NULL
D.	NULL
Yao	NULL
,	NULL
S.	NULL
Burger	NULL
,	NULL
M.	NULL
Kamoun	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Kant	NULL
.	NULL

1988	NULL
.	NULL

Two	NULL
regions	NULL
within	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
promoter	NULL
are	NULL
important	NULL
for	NULL
inducible	NULL
IL-2	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

141:662-666	NULL
.	NULL

Wiskocil	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Weiss	NULL
,	NULL
J.	NULL
Imboden	NULL
,	NULL
R.	NULL
Kamin-Lewis	NULL
,	NULL
and	NULL
J.	NULL
Stobo	NULL
.	NULL

1985	NULL
.	NULL

Activation	NULL
of	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
:	NULL
a	NULL
two-stimulus	NULL
requirement	NULL
in	NULL
the	NULL
pre-translational	NULL
events	NULL
involved	NULL
in	NULL
the	NULL
coordinate	NULL
expression	NULL
of	NULL
interleukin	NULL
2	NULL
and	NULL
gamma-interferon	NULL
genes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

134:1599-1603	NULL
.	NULL

